FiscalNote (NOTE) 10-Q 10 May 24 2024 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2024	May 06, 2024
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Entity Registrant Name	FISCALNOTE HOLDINGS, INC.
Entity Central Index Key	0001823466
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity File Number	001-396972
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	88-3772307
Entity Address, Address Line One	1201 Pennsylvania Avenue NW, 6th Floor
Entity Address, City or Town	Washington, D.C.
Entity Address, State or Province	WA
Entity Address, Postal Zip Code	20004
City Area Code	202
Local Phone Number	793-5300
Document Quarterly Report	true
Document Transition Report	false
Common Class A
Entity Common Stock, Shares Outstanding		126,087,528
Title of 12(b) Security	Class A common stock, par value $0.0001 per share
Trading Symbol	NOTE
Security Exchange Name	NYSE
Common Class B
Entity Common Stock, Shares Outstanding		8,290,921
Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share
Title of 12(b) Security	Warrants to purchase one share of Class A common stock, each at an exercise price of $11.50 per share
Trading Symbol	NOTE.WS
Security Exchange Name	NYSE

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 36,464	$ 16,451
Restricted cash	852	849
Short-term investments	7,134	7,134
Accounts receivable, net	14,381	16,931
Costs capitalized to obtain revenue contracts, net	3,156	3,326
Prepaid expenses	4,000	2,593
Other current assets	3,679	2,521
Total current assets	69,666	49,805
Property and equipment, net	5,859	6,141
Capitalized software costs, net	13,762	13,372
Noncurrent costs capitalized to obtain revenue contracts, net	3,790	4,257
Operating lease assets	18,070	17,782
Goodwill	164,334	187,703
Customer relationships, net	46,720	53,917
Database, net	18,274	18,838
Other intangible assets, net	16,786	18,113
Other non-current assets	499	633
Total assets	357,760	370,561
Current liabilities:
Current maturities of long-term debt	67	105
Accounts payable and accrued expenses	11,101	12,909
Deferred revenue, current portion	45,034	43,530
Customer deposits	839	3,032
Contingent liabilities from acquisitions, current portion	113	130
Operating lease liabilities, current portion	3,395	3,066
Other current liabilities	3,212	2,878
Total current liabilities	63,761	65,650
Long-term debt, net of current maturities	152,962	222,310
Deferred tax liabilities	2,062	2,178
Deferred revenue, net of current portion	389	875
Operating lease liabilities, net of current portion	25,845	26,162
Public and private warrant liabilities	3,840	4,761
Other non-current liabilities	2,805	5,166
Total liabilities	251,664	327,102
Commitment and contingencies (Note 17)
Stockholders' equity:
Additional paid-in capital	866,932	860,485
Accumulated other comprehensive income (loss)	4,969	(622)
Accumulated deficit	(765,817)	(816,416)
Total stockholders' equity	106,096	43,459
Total liabilities and stockholders' equity	357,760	370,561
Common Class A
Stockholders' equity:
Common stock value	11	11
Common Class B
Stockholders' equity:
Common stock value	$ 1	$ 1

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheet (Parenthetical) (Unaudited) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Common Class A
Common stock par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	1,700,000,000	1,700,000,000
Common stock, shares, issued	122,749,497	121,679,829
Common stock, shares, outstanding	122,749,497	121,679,829
Common Class B
Common stock par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	9,000,000	9,000,000
Common stock, shares, issued	8,290,921	8,290,921
Common stock, shares, outstanding	8,290,921	8,290,921

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Revenues:
Total revenues		$ 32,112	$ 31,529
Operating expenses:
Cost of revenues	[1]	7,244	8,937
Research and development	[1]	3,480	5,120
Sales and marketing	[1]	9,415	12,298
Editorial	[1]	4,660	4,265
General and administrative	[1]	16,076	18,221
Amortization of intangible assets	[1]	2,685	2,814
Impairment of goodwill	[1]		5,837
Transaction (gains) costs, net	[1]	(4)	1,408
Total operating expenses	[1]	43,556	58,900
Operating loss		(11,444)	(27,371)
Gain on sale of business (Note 4)		(71,599)
Interest expense, net		7,362	6,681
Change in fair value of financial instruments		527	(14,680)
Other expense (income), net		241	(129)
Net income (loss) before income taxes		52,025	(19,243)
Provision from income taxes		1,426	30
Net income (loss)		50,599	(19,273)
Other comprehensive income (loss)		5,591	(359)
Total comprehensive income (loss)		$ 56,190	$ (19,632)
Earnings (Loss) per share attributable to common shareholders (Note 14):
Basic		$ 0.39	$ (0.14)
Diluted		$ 0.37	$ (0.14)
Weighted average shares used in computing earnings (loss) per share attributable to common shareholders:
Basic		130,712,032	133,082,639
Diluted		146,027,085	133,082,639
Subscription
Revenues:
Total revenues		$ 29,626	$ 28,467
Advisory, advertising, and other
Revenues:
Total revenues		$ 2,486	$ 3,062
[1] Amounts include stock-based compensation expenses, as follows: Three Months Ended March 31, 2024 2023 Cost of revenues $ 101 $ 58 Research and development 310 390 Sales and marketing 426 360 Editorial 100 66 General and administrative 5,238 5,632

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Operations and Comprehensive Loss (Parenthetical) (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Stock-based compensation expenses	$ 131	$ 1,124
Cost of Revenues
Stock-based compensation expenses	101	58
Research and Development
Stock-based compensation expenses	310	390
Sales and Marketing Expense
Stock-based compensation expenses	426	360
Editorial
Stock-based compensation expenses	100	66
General and Administrative
Stock-based compensation expenses	$ 5,238	$ 5,632

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Changes in Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Adoption of new accounting standard	Common Class A	Common Stock	Common Stock Common Class A	Additional Paid-in Capital	Additional Paid-in Capital Common Class A	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit Adoption of new accounting standard
Beginning Balance at Dec. 31, 2022	$ 144,690	$ (212)		$ 13		$ 846,205		$ (785)	$ (700,743)	$ (212)
Balance, shares at Dec. 31, 2022				131,416,516
Accounting Standards Update [Extensible Enumeration]	us-gaap:AccountingStandardsUpdate202006Member
Issuance of Class A common stock upon vesting of restricted share units, shares					287,157
Exercise of stock options			$ 264				$ 264
Exercise of stock options, shares					194,775
Issuance of Class A common stock upon settlement of contingent consideration, shares					83,393
Issuance of Class A common stock upon settlement of contingent consideration			196				196
Shares issued in business acquisitions			$ 9,539				$ 9,539
Shares issued in business acquisitions, shares					1,885,149
Stock-based compensation expense	$ 6,506					6,506
Withholding taxes on net share settlement of stock-based compensation and option exercises	(917)					(917)
Net income (loss)	(19,273)								(19,273)
Foreign currency translation loss	(359)							(359)
Ending Balance at Mar. 31, 2023	140,434			$ 13		861,793		(1,144)	(720,228)
Balance, share at Mar. 31, 2023				133,866,990
Beginning Balance at Dec. 31, 2023	43,459			$ 12		860,485		(622)	(816,416)
Balance, shares at Dec. 31, 2023				129,970,750
Issuance of Class A common stock upon vesting of restricted share units, shares					867,341
Issuance of Class A common stock upon employee stock purchase plan	196					196
Issuance of Class A common stock upon employee stock purchase plan, shares					202,327
Stock-based compensation expense	6,175					6,175
Withholding taxes on net share settlement of stock-based compensation and option exercises	76					76
Change in fair value of debt instruments (Note 16)	5,707							5,707
Net income (loss)	50,599								50,599
Foreign currency translation loss	(116)							(116)
Ending Balance at Mar. 31, 2024	$ 106,096			$ 12		$ 866,932		$ 4,969	$ (765,817)
Balance, share at Mar. 31, 2024				131,040,418

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Operating Activities:
Net income (loss)		$ 50,599	$ (19,273)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation		304	336
Amortization of intangible assets and capitalized software development costs		5,113	5,411
Amortization of deferred costs to obtain revenue contracts		1,009	832
Gain on sale of business (Note 4)		(71,599)
Impairment of goodwill	[1]		5,837
Non-cash operating lease expense		297	1,832
Stock-based compensation		6,175	6,506
Other non-cash expenses			190
Bad debt expense		29	156
Change in fair value of acquisition contingent consideration		(4)	(156)
Unrealized loss on securities		49
Change in fair value of financial instruments		527	(14,680)
Deferred income taxes		(71)	(218)
Paid-in-kind interest, net		2,035	970
Non-cash interest expense		737	1,074
Changes in operating assets and liabilities:
Accounts receivable, net		1,320	(696)
Prepaid expenses and other current assets		(1,924)	619
Costs capitalized to obtain revenue contracts, net		(932)	(1,126)
Other non-current assets		148	27
Accounts payable and accrued expenses		460	(3,225)
Deferred revenue		10,436	10,002
Customer deposits		(1,239)	(1,923)
Other current liabilities		318	(1,222)
Contingent liabilities from acquisitions, net of current portion		(13)	(39)
Operating lease liabilities		(969)	(4,052)
Other non-current liabilities		(64)	(8)
Net cash provided by (used in) operating activities		2,741	(12,826)
Investing Activities:
Capital expenditures		(1,692)	(1,869)
Cash proceeds from the sale of business, net (Note 4)		90,884
Cash paid for business acquisitions, net of cash acquired			(5,010)
Net cash provided by (used in) investing activities		89,192	(6,879)
Financing Activities:
Proceeds from long-term debt, net of issuance costs		801	6,000
Principal payments of long-term debt		(65,727)	(27)
Payment of deferred financing costs		(7,068)
Proceeds from exercise of stock options and ESPP purchases		196	264
Net cash (used in) provided by financing activities		(71,798)	6,237
Effects of exchange rates on cash		(119)	(251)
Net change in cash, cash equivalents, and restricted cash		20,016	(13,719)
Cash, cash equivalents, and restricted cash, beginning of period		17,300	61,223
Cash, cash equivalents, and restricted cash, end of period		37,316	47,504
Supplemental Noncash Investing and Financing Activities:
Warrants issued in conjunction with long-term debt issuance			178
Amounts held in escrow related to the sale of Board.org		785
Property and equipment purchases included in accounts payable		124	121
Supplemental Cash Flow Activities:
Cash paid for interest		5,303	4,740
Cash paid for taxes		$ 2	$ 112
[1] Amounts include stock-based compensation expenses, as follows: Three Months Ended March 31, 2024 2023 Cost of revenues $ 101 $ 58 Research and development 310 390 Sales and marketing 426 360 Editorial 100 66 General and administrative 5,238 5,632

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ 50,599	$ (19,273)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024 shares
Trading Arrangements, by Individual
Material Terms of Trading Arrangement	Insider Trading Arrangements Tim Hwang , the Company’s Chairman, Chief Executive Officer and Co-Founder , adopted a trading plan on March 20, 2024 , and Gerald Yao , the Company’s Chief Strategy Officer, Global Head of ESG, and Co-Founder , adopted a trading plan on March 19, 2024 (each, a "Trading Plan"). Each Trading Plan is intended to satisfy the Rule 10b5-1 affirmative defense. Mr, Hwang's Trading Plan covers the disposition of up to 25,000 shares per month of the Company’s Class A common stock, and will terminate on May 30, 2025 , unless earlier terminated in accordance with its terms. Mr. Yao's Trading Plan covers the disposition of up to 2,750 shares per month of the Company's Class A common stock, and will terminate on May 30, 2025 , unless earlier terminated in accordance with its terms.
Gerald Yao
Trading Arrangements, by Individual
Name	Gerald Yao
Title	Chief Strategy Officer, Global Head of ESG, and Co-Founder
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	March 19, 2024
Rule 10b5-1 Arrangement Terminated	true
Termination Date	May 30, 2025
Aggregate Available	2,750
Tim Hwang
Trading Arrangements, by Individual
Name	Tim Hwang
Title	Chairman, Chief Executive Officer and Co-Founder
Rule 10b5-1 Arrangement Adopted	true
Adoption Date	March 20, 2024
Rule 10b5-1 Arrangement Terminated	true
Termination Date	May 30, 2025
Aggregate Available	25,000

Summary of Business and Signifi

Summary of Business and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Summary of Business and Significant Accounting Policies	1. Summary of Business and Significant Accounting Policies Description of Business FiscalNote Holdings, Inc. (“FiscalNote,” or the “Company”) is a leading technology provider of global policy and market intelligence. It delivers critical, actionable legal and policy insights in a rapidly evolving political, regulatory and macroeconomic environment. By combining artificial intelligence (AI) technology, other technologies with analytics, workflow tools, and expert peer insights, FiscalNote empowers customers to manage policy, address regulatory developments, and mitigate global risk. FiscalNote ingests unstructured legislative and regulatory data, and employs AI and data science to deliver structured, relevant and actionable information in order to facilitate key operational and strategic decisions by global enterprises, midsized and smaller businesses, government institutions, trade groups, and nonprofits. FiscalNote delivers that intelligence through its suite of public policy and issues management products. The Company is headquartered in Washington, D.C. Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances have been eliminated in consolidation. These condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of the Company’s management, the unaudited condensed consolidated financial statements include all adjustments necessary for the fair presentation of the Company’s balance sheet and its results of operations, including its comprehensive loss, temporary equity, stockholders' equity (deficit), and cash flows. All adjustments are of a normal recurring nature. The results for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for any subsequent quarter or for the fiscal year ending December 31, 2024. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 . Liquidity and Going Concern Historically the Company’s cash flows from operations have not been sufficient to fund its current operating model and the Company funded operations through raising equity and debt. The Company's ability to maintain its minimum cash requirement, fund its future cash interest requirements under its senior term loan and fund its operations depend in part on general economic, financial, competitive, legislative, regulatory and other conditions that may be beyond the Company's control. Accordingly, the Company continues to closely monitor expenses to assess whether any immediate, or long-term changes, are necessary to maintain compliance with its financial covenants. The Company’s cash, cash equivalents, restricted cash, and short-term investments were $ 44.5 million at March 31, 2024, compared with $ 24.4 million at December 31, 2023. Further, the Company had a negative working capital balance of $ 38.5 million (excluding cash and short-term investments) at March 31, 2024 and had an accumulated deficit of $ 765.8 million and $ 816.4 million as of March 31, 2024 and December 31, 2023, respectively. The Company has incurred net losses of $ 21.0 million (excluding the effect of the gain on sale of business) and $ 19.3 million for the three months ended March 31, 2024 and 2023, respectively. Management expects that significant on-going operating and capital expenditures will be necessary to continue to implement the Company’s business plan of entering new markets, future acquisitions, and infrastructure and product development. In addition, as disclosed in Note 8, “Debt”, the Company is subject to certain financial covenants. The Company’s ability to maintain compliance with these financial covenants are based on the Company’s current expectations regarding continued growth in revenues, collections, cost structure, current cash burn rate and other operating assumptions. The Company believes our cash on hand at March 31, 2024, proceeds from our expected product sales, and available borrowings under our Senior Term Loan for certain acquisition activity, will be sufficient to meet our obligations and our required covenants for at least the next twelve months from the date of this filing . Segments The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance. Over the past several years, the Company has completed a number of acquisitions. These acquisitions have allowed the Company to expand its offerings, presence, and reach in various market segments. While the Company has offerings in multiple market segments and operates in multiple countries, the Company’s business operates in one operating segment because the Company’s CODM evaluates the Company’s financial information and resources, and assesses the performance of these resources, on a consolidated basis. Earnings per Share Basic earnings per share (EPS) is calculated by dividing the net income or loss available to common stockholders by the weighted average number of shares of common stock outstanding for the period without consideration for common stock equivalents. Diluted EPS is computed by dividing the net income or loss available to common stockholders by the weighted average number of shares of common stock outstanding for the period and the weighted average number of dilutive common stock equivalents outstanding for the period determined using the if-converted method (convertible debt instruments) or treasury-stock method (warrants and share-based payment arrangements). For purposes of this calculation, common stock issuable upon conversion of debt, options and warrants are considered to be common stock equivalents and are only included in the calculation of diluted earnings per share when their effect is dilutive. Fair Value of Financial Instruments The Company has elected the fair value option on the subordinated convertible promissory notes issued as part of the Dragonfly acquisition, refer to Note 4, "Business Combinations" and Note 8, "Debt" for further details, and for the New GPO Note and Era Convertible Notes, refer to Note 8, "Debt" for further details. The Company records changes in fair value through the condensed consolidated statement of operations where the portion of the change that results from a change in the instrument-specific credit risk is recorded separately in accumulated other comprehensive income, if applicable. Additionally, under the fair value option, all issuance costs are expensed in the period that the debt is incurred. Investments The Company has invested in highly liquid investments that have investment-grade ratings. These investments are accounted for at fair value through the condensed consolidated statement of operations. The Company is able to easily liquidate these into cash; accordingly, the Company has presented these investments as available for current operations and are presented as short-term investments within current assets in the condensed consolidated balance sheets. Purchases and sales of short-term investments are classified in the investing section of our consolidated statement of cash flows. Concentrations of Risks Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company generally maintains its cash and cash equivalents with various nationally recognized financial institutions. The Company’s cash and cash equivalents at times exceed amounts guaranteed by the Federal Deposit Insurance Corporation. The Company considers cash on deposit and all highly liquid investments with original maturities of three months or less to be cash and cash equivalents. At March 31, 2024 , approximately 77 % of the Company’s cash and cash equivalents were held at JPMorgan Chase Bank, N.A. The Company does not require collateral for accounts receivable. The Company maintains an allowance for its doubtful accounts receivable due to estimated credit losses. This allowance is based upon historical loss patterns, the number of days billings are past due, collection history of each customer, an evaluation of the potential risk of loss associated with delinquent accounts and current market conditions and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss patterns. The Company records the allowance against bad debt expense through the condensed consolidated statements of operations, included in sales and marketing expense, up to the amount of revenues recognized to date. Any incremental allowance is recorded as an offset to deferred revenue on the condensed consolidated balance sheets. Receivables are written off and charged against the recorded allowance when the Company has exhausted collection efforts without success. As of March 31, 2024 and December 31, 2023 , allowance for credit losses of $ 1,120 and $ 1,252 , respectively, was included in the accounts receivable, net balance. No single customer accounted for more than 10 % of the Company's accounts receivable balance as of March 31, 2024 and December 31, 2023. Revenue derived from the U.S. Federal Government was 17 % of revenue for both of the three months ended March 31, 2024 and 2023, respectively. As of both of March 31, 2024 and December 31, 2023 , assets located in the United States were approximately 85 % percent of total assets. As of March 31, 2024 one vendor accounted for more than 10 % of the Company's accounts payable balance. No vendors individually accounted for more than 10 % of the Company’s accounts payable as of December 31, 2023 . During the three months ended March 31, 2024 and March 31, 2023, one vendor represented more than 10 % of the total purchases made. Recently Adopted Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13 Financial Instruments – Credit Losses (ASC 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13") guidance with respect to measuring credit losses on financial instruments, including trade receivables. The guidance eliminates the probable initial recognition threshold that was previously required prior to recognizing a credit loss on financial instruments. The credit loss estimate now reflects an entity's current estimate of all future expected credit losses. Under the previous guidance, an entity only considered past events and current conditions. The Company adopted ASC 2016-13 on January 1, 2023 using the modified retrospective transition method. Upon adoption, the Company recorded a $ 212 cumulative-effect adjustment to accumulated deficit on the condensed consolidated balance sheets, our allowance for doubtful accounts receivable changed from $ 468 at December 31, 2022 to $ 680 at January 1, 2023 . In August 2020, the FASB issued ASU 2020-06 Debt – Debt with Conversion and Other Options (ASC 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (ASC 815-40) ("ASU 2020-06") guidance modifying the requirements for the accounting for convertible instruments and contracts in an entity’s own equity. The modifications eliminate certain accounting models for convertible debt instruments, eliminate certain requirements for equity classification of embedded derivatives and align earnings per share calculations for convertible instruments. The Company adopted ASC 2020-06 on January 1, 2023 using the modified retrospective approach. The adoption of ASC 2020-06 did not have a material impact on the Company's condensed consolidated financial statements. Recent Accounting Pronouncements Not Yet Effective In November 2023, the FASB issued ASU 2023-07 Segment Reporting (Topic 280) guidance for segment reporting. The new guidance amends segment reporting to include significant segment expenses. The guidance is effective for the Company beginning with our annual report for the year ended December 31, 2024, and the subsequent interim periods and is required to be disclosed retrospectively to all prior periods presented. The Company does not expect that this guidance will have a significant impact on our disclosures. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . The amendments in the ASU enhance income tax disclosures, primarily through standardization, disaggregation of rate reconciliation categories, and income taxes paid by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption allowed. We are currently evaluating the impact of adoption on our financial disclosures.

Business Combination

Business Combination	3 Months Ended
	Mar. 31, 2024
Acquisitions and Dispositions	Note 4. Acquisitions and Dispositions 2024 Disposition On March 11, 2024, the Company entered into an agreement (the "Purchase Agreement") to sell the equity of the Company's subsidiary owning and operating its Board.org business ("Board.org") with Exec Connect Intermediate LLC (the “Buyer”). On March 11, 2024, after adjustments based on Board.org’s working capital, indebtedness and transaction expenses, as well as retention payments payable to certain employees of Board.org, the Company received $ 90,905 in cash (excluding $ 785 of the purchase price that was deposited into escrow to satisfy certain potential post-closing purchase price adjustments and indemnification claims and including $ 21 of cash acquired by the Buyer). The Company is entitled to receive an earn-out payment of up to $ 8,000 , less the amount of certain retention payments potentially owing to the former Board.org employees, if the Board.org business achieves specified revenue targets for fiscal year 2024. The Purchase Agreement contains representations, warranties and indemnification obligations of the parties customary for transactions similar to those contemplated by the Purchase Agreement. As a result of the sale of Board.org, the Company recorded a pre-tax gain on disposal of $ 71,599 , inclusive of the $ 785 of funds placed in escrow that the Company anticipates receiving and $ 50 of estimated post-closing purchase price adjustment which are included in other current assets. The proceeds from the sale of Board.org were used in part to prepay $ 65,700 of term loans under the Company’s Credit Agreement, and pay $ 7,068 of related prepayment and exit fees associated with the retired amount. The remaining $ 18,137 of net proceeds were retained by the Company for general corporate purposes. As part of the sale the Company recorded a current tax liability for federal and state income tax of $ 1,448 and a non-cash deferred tax charge of $ 280 . The Company determined that Board.org was not a significant subsidiary, and the disposition of Board.org did not constitute a strategic shift that would have a major effect on the Company’s operations or financial results. As a result, the results of operations for Board.org were not reported as discontinued operations under the guidance of ASC 205 “Presentation of Financial Statements." Pursuant to the Employee Lease Agreement entered into in connection with the closing of the sale of Board.org, the Company is the employer of record for the Board.org employees. Under the terms of the Employee Lease agreement, the Company is responsible for the payment of salaries and benefits to the Board.org employees at the direction of the buyer, until the buyer legally assumes those employees. The Company will be reimbursed by the buyer for the actual costs incurred pursuant to the Employee Lease Agreement. Accordingly, at March 31, 2024 the Company is due $ 378 from the buyer for payroll and benefit costs paid by the Company during the period from March 11, 2024 to March 31, 2024, which has been presented in other current assets on the condensed consolidated balance sheet. Additionally, the Company entered into a Transition Services Agreement in connection with the closing of the sale of Board.org whereby the Company will provide certain transitional support services for a period of time following the closing and the buyer will reimburse FiscalNote for certain direct costs of those services. No material costs were incurred under the Transition Services Agreement during the period from March 11, 2024 to March 31, 2024. 2023 Acquisition Dragonfly Acquisition On January 27, 2023, the Company entered into a Sale and Purchase Agreement for all of the issued and outstanding share capital of Dragonfly Eye Limited ("Dragonfly"), a UK- based SaaS-based geopolitical and security intelligence provider of actionable data and analysis delivered through Dragonfly's SaaS-based, proprietary Security Intelligence and Analysis Service subscription platform and API. The aggregate purchase price consisted of (i) $ 5.6 million in cash ( £ 4.5 million pounds sterling) , (ii) 1,885,149 shares of the Company’s Class A Common Stock, and (iii) $ 11.1 million ( £ 8.9 million pounds sterling) in aggregate principal amount of subordinated convertible promissory notes (“Seller Convertible Notes”). The Company incurred expenses of $ 1,272 in connection with the transaction during the year ended December 31, 2023 (inclusive of $ 446 of amounts paid on January 27, 2023 that were recognized as expense during the three months ended March 31, 2023). The acquisition date fair value of the consideration transferred for Dragonfly consisted of the following: Cash $ 5,617 Fair value of Class A common stock 9,539 Fair value of Seller Convertible Notes 8,635 Fair value of contingent consideration 1,445 Total $ 25,236 The Class A common stock issued as consideration as part of the acquisition of Dragonfly represents non-cash activity on the condensed consolidated statement of stockholders equity and condensed consolidated statement of cash flows. Certain employees of Dragonfly are eligible for employee earnout bonus awards ("Employee Earnout Awards") based on 2024 revenue targets. The Employee Earnout Awards are subject to forfeiture in the event that Dragonfly does not achieve its revenue target or these employees terminate their employment. Any Employee Earnout Awards that are forfeited are reallocated to the other eligible employees. The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of acquisition: Cash and cash equivalents $ 607 Current assets, net 3,690 Property and equipment, net 18 Intangible assets 9,600 Deferred revenues ( 3,933 ) Current liabilities ( 1,764 ) Deferred tax liabilities ( 1,517 ) Total net assets acquired 6,701 Goodwill 18,535 Total purchase price $ 25,236 The following table sets forth the components of identified intangible assets acquired and their estimated useful lives as of the date of acquisition: Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 7,300 6 , 10 (a) Developed technology 1,750 10 Tradename 550 3 Total intangible assets acquired $ 9,600 (a) Includes two separate customer relationships with two different useful lives The fair values of the customer relationships, developed technology and tradename were determined using the income approach. The approaches used to estimate the fair values use significant unobservable inputs including revenue and cash flow forecasts, customer attrition rates, and appropriate discount rates. The purchase price allocation includes UK deferred income tax assets and liabilities for acquired book and tax basis differences. Goodwill recorded for this acquisition is no t tax deductible.
DSAC
Acquisitions and Dispositions	2. Business Combination with DSAC On July 29, 2022, the Company consummated the transactions contemplated by the Agreement and Plan of Merger, dated as of November 7, 2021, and as amended on May 9, 2022, (the “Merger Agreement”), by and among FiscalNote Holdings, Inc., a Delaware corporation (“Old FiscalNote”), Duddell Street Acquisition Corp., a Cayman Islands exempted company (“DSAC”), and Grassroots Merger Sub, Inc., a Delaware Corporation and a wholly owned direct subsidiary of DSAC (“Merger Sub” and, together with DSAC, the “DSAC Parties”). Pursuant to these transactions, Merger Sub merged with and into Old FiscalNote, with Old FiscalNote becoming a wholly owned subsidiary of DSAC (the “Business Combination” and, collectively with the other transactions described in the Business Combination Agreement, the “Transactions”). In connection with the closing of the Transactions, DSAC domesticated and continued as a Delaware corporation under the name of “FiscalNote Holdings, Inc.” (“New FiscalNote”). Unless the context otherwise requires, references in this Quarterly Report on Form 10-Q to the “Company,” “FiscalNote,” “we,” “us,” or “our” refer to the business of Old FiscalNote, which became the business of New FiscalNote and its subsidiaries following the closing on July 29, 2022. Subseq uent to the closing of the Business Combination, the Company's Class A common stock and public warrants began trading on the New York Stock Exchange (“NYSE”) under the symbols “NOTE” and “NOTE WS,” respectively. The Company accounted for the Business Combination as a reverse recapitalization whereby Old FiscalNote was determined as the accounting acquirer and DSAC as the accounting acquiree. Accordingly, the Business Combination was treated as the equivalent of Old FiscalNote issuing stock for the net assets of DSAC, accompanied by a recapitalization. The net assets of DSAC are stated at historical cost, with no goodwill or other intangible assets recorded. In connection with the closing of the Business Combination Agreement, FiscalNote also entered into the Credit Agreement with Runway Growth Finance Corp., ORIX Growth Capital, LLC, Clover Orochi LLC, and ACM ASOF VIII SaaS FinCo LLC (together the “New Senior Lenders”), pursuant to which a new senior term loan was consummated simultaneously with the Closing (the "Senior Term Loan").

Revenues

Revenues	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenues	3. Revenues Disaggregation of Revenue The following table depicts the Company's disaggregated revenue for the periods presented: Three Months Ended March 31, 2024 2023 Subscription $ 29,626 $ 28,467 Advisory 1,257 1,113 Advertising 514 418 Books 148 584 Other revenue 567 947 Total $ 32,112 $ 31,529 Revenue by Geographic Locations The following table depicts the Company’s revenue by geographic operations for the periods presented: Three Months Ended March 31, 2024 2023 North America $ 25,997 $ 26,152 Europe 5,269 4,100 Australia 303 289 Asia 543 988 Total $ 32,112 $ 31,529 Revenues by geography are determined based on the region of the Company's contracting entity, which may be different than the region of the customer. North America revenue consists solely of revenue attributed to the United States. For the three months ended March 31, 2024 and 2023 , revenue attributed to the United Kingdom represented approximately thirteen percent and ten percent of total revenues, respectively. No other foreign country represented more than five percent of total revenue during the three months ended March 31, 2024 and 2023. Contract Assets The Company had contract assets of $ 1,044 and $ 1,183 , as of March 31, 2024 and December 31, 2023, respectively. Contract assets are generated when contractual billing schedules differ from the timing of revenue recognition or cash collections. They represent a conditional right to consideration for satisfied performance obligations that becomes a receivable when the conditions are satisfied. They are recorded as part of other current assets on the condensed consolidated balance sheets. Deferred Revenue Details of the Company’s deferred revenue for the periods presented are as follows: Balance at December 31, 2022 $ 36,487 Acquired deferred revenue 4,013 Revenue recognized in the current period from amounts in the prior balance ( 16,610 ) New deferrals, net of amounts recognized in the current period 25,928 Effects of foreign currency 32 Balance at March 31, 2023 $ 49,850 Balance at December 31, 2023 $ 44,405 Sale of Board.org ( 9,117 ) Revenue recognized in the current period from amounts in the prior balance ( 19,249 ) New deferrals, net of amounts recognized in the current period 29,502 Effects of foreign currency ( 118 ) Balance at March 31, 2024 $ 45,423 Costs to Obtain During the three months ended March 31, 2024 and 2023, the Company capitalized $ 941 and $ 1,114 of costs to obtain revenue contracts. The Company amortized costs to obtain revenue contracts in the amount of $ 1,009 and $ 832 to sales and marketing expense during the three months ended March 31, 2024 and 2023 , respectively. There were no impairments of costs to obtain revenue contracts for the three months ended March 31, 2024 and 2023. Unsatisfied Performance Obligations At March 31, 2024, the Company had $ 90,981 of remaining contract consideration for which revenue has not been recognized due to unsatisfied performance obligations. The Company expects to recognize this over the next five years .

Acquisitions and Dispositions

Acquisitions and Dispositions	3 Months Ended
	Mar. 31, 2024
Business Combinations [Abstract]
Acquisitions and Dispositions	Note 4. Acquisitions and Dispositions 2024 Disposition On March 11, 2024, the Company entered into an agreement (the "Purchase Agreement") to sell the equity of the Company's subsidiary owning and operating its Board.org business ("Board.org") with Exec Connect Intermediate LLC (the “Buyer”). On March 11, 2024, after adjustments based on Board.org’s working capital, indebtedness and transaction expenses, as well as retention payments payable to certain employees of Board.org, the Company received $ 90,905 in cash (excluding $ 785 of the purchase price that was deposited into escrow to satisfy certain potential post-closing purchase price adjustments and indemnification claims and including $ 21 of cash acquired by the Buyer). The Company is entitled to receive an earn-out payment of up to $ 8,000 , less the amount of certain retention payments potentially owing to the former Board.org employees, if the Board.org business achieves specified revenue targets for fiscal year 2024. The Purchase Agreement contains representations, warranties and indemnification obligations of the parties customary for transactions similar to those contemplated by the Purchase Agreement. As a result of the sale of Board.org, the Company recorded a pre-tax gain on disposal of $ 71,599 , inclusive of the $ 785 of funds placed in escrow that the Company anticipates receiving and $ 50 of estimated post-closing purchase price adjustment which are included in other current assets. The proceeds from the sale of Board.org were used in part to prepay $ 65,700 of term loans under the Company’s Credit Agreement, and pay $ 7,068 of related prepayment and exit fees associated with the retired amount. The remaining $ 18,137 of net proceeds were retained by the Company for general corporate purposes. As part of the sale the Company recorded a current tax liability for federal and state income tax of $ 1,448 and a non-cash deferred tax charge of $ 280 . The Company determined that Board.org was not a significant subsidiary, and the disposition of Board.org did not constitute a strategic shift that would have a major effect on the Company’s operations or financial results. As a result, the results of operations for Board.org were not reported as discontinued operations under the guidance of ASC 205 “Presentation of Financial Statements." Pursuant to the Employee Lease Agreement entered into in connection with the closing of the sale of Board.org, the Company is the employer of record for the Board.org employees. Under the terms of the Employee Lease agreement, the Company is responsible for the payment of salaries and benefits to the Board.org employees at the direction of the buyer, until the buyer legally assumes those employees. The Company will be reimbursed by the buyer for the actual costs incurred pursuant to the Employee Lease Agreement. Accordingly, at March 31, 2024 the Company is due $ 378 from the buyer for payroll and benefit costs paid by the Company during the period from March 11, 2024 to March 31, 2024, which has been presented in other current assets on the condensed consolidated balance sheet. Additionally, the Company entered into a Transition Services Agreement in connection with the closing of the sale of Board.org whereby the Company will provide certain transitional support services for a period of time following the closing and the buyer will reimburse FiscalNote for certain direct costs of those services. No material costs were incurred under the Transition Services Agreement during the period from March 11, 2024 to March 31, 2024. 2023 Acquisition Dragonfly Acquisition On January 27, 2023, the Company entered into a Sale and Purchase Agreement for all of the issued and outstanding share capital of Dragonfly Eye Limited ("Dragonfly"), a UK- based SaaS-based geopolitical and security intelligence provider of actionable data and analysis delivered through Dragonfly's SaaS-based, proprietary Security Intelligence and Analysis Service subscription platform and API. The aggregate purchase price consisted of (i) $ 5.6 million in cash ( £ 4.5 million pounds sterling) , (ii) 1,885,149 shares of the Company’s Class A Common Stock, and (iii) $ 11.1 million ( £ 8.9 million pounds sterling) in aggregate principal amount of subordinated convertible promissory notes (“Seller Convertible Notes”). The Company incurred expenses of $ 1,272 in connection with the transaction during the year ended December 31, 2023 (inclusive of $ 446 of amounts paid on January 27, 2023 that were recognized as expense during the three months ended March 31, 2023). The acquisition date fair value of the consideration transferred for Dragonfly consisted of the following: Cash $ 5,617 Fair value of Class A common stock 9,539 Fair value of Seller Convertible Notes 8,635 Fair value of contingent consideration 1,445 Total $ 25,236 The Class A common stock issued as consideration as part of the acquisition of Dragonfly represents non-cash activity on the condensed consolidated statement of stockholders equity and condensed consolidated statement of cash flows. Certain employees of Dragonfly are eligible for employee earnout bonus awards ("Employee Earnout Awards") based on 2024 revenue targets. The Employee Earnout Awards are subject to forfeiture in the event that Dragonfly does not achieve its revenue target or these employees terminate their employment. Any Employee Earnout Awards that are forfeited are reallocated to the other eligible employees. The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of acquisition: Cash and cash equivalents $ 607 Current assets, net 3,690 Property and equipment, net 18 Intangible assets 9,600 Deferred revenues ( 3,933 ) Current liabilities ( 1,764 ) Deferred tax liabilities ( 1,517 ) Total net assets acquired 6,701 Goodwill 18,535 Total purchase price $ 25,236 The following table sets forth the components of identified intangible assets acquired and their estimated useful lives as of the date of acquisition: Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 7,300 6 , 10 (a) Developed technology 1,750 10 Tradename 550 3 Total intangible assets acquired $ 9,600 (a) Includes two separate customer relationships with two different useful lives The fair values of the customer relationships, developed technology and tradename were determined using the income approach. The approaches used to estimate the fair values use significant unobservable inputs including revenue and cash flow forecasts, customer attrition rates, and appropriate discount rates. The purchase price allocation includes UK deferred income tax assets and liabilities for acquired book and tax basis differences. Goodwill recorded for this acquisition is no t tax deductible.

Leases

Leases	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Leases	5. Leases The Company has operating leases, principally for corporate offices under non-cancelable operating leases that expire at various dates through 2031. The non-cancellable base terms of these leases typically range from one to nine years . Certain lease agreements include options to renew or terminate the lease, which if not reasonably certain to be exercised are therefore not factored into the determination of lease payments. The following table details the composition of lease expense for the periods presented: Three Months Ended March 31, 2024 2023 Operating lease cost $ 1,238 $ 2,585 Variable lease cost 94 155 Short-term lease cost 37 178 Total lease costs $ 1,369 $ 2,918 Sublease income $ ( 26 ) $ ( 1,364 ) Cash payments related to operating lease liabilities were $ 1,499 and $ 4,797 (inclusive of $ 1,682 lease termination fee) for the three months ended March 31, 2024 and 2023 , respectively.

Intangible Assets

Intangible Assets	3 Months Ended
	Mar. 31, 2024
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Intangible Assets	6. Intangible Assets The following table summarizes the gross carrying amounts and accumulated amortization of the Company’s intangible assets by major class: March 31, 2024 December 31, 2023 Weighted Average Gross Carrying Amount Accumulated Amortization Accumulated Impairment Net Gross Carrying Amount Accumulated Amortization Impairment Net Remaining Useful Life (Years) March 31, 2024 Customer relationships $ 76,071 $ ( 27,116 ) $ ( 2,235 ) $ 46,720 $ 88,544 $ ( 32,392 ) $ ( 2,235 ) $ 53,917 8.5 Developed technology 29,968 ( 20,338 ) ( 1,909 ) 7,721 37,205 ( 26,743 ) ( 1,909 ) 8,553 6.7 Databases 29,864 ( 11,590 ) - 18,274 29,895 ( 11,057 ) - 18,838 8.6 Tradenames 11,119 ( 3,789 ) ( 579 ) 6,751 12,077 ( 4,367 ) ( 579 ) 7,131 8.2 Expert network 2,669 ( 1,391 ) - 1,278 2,692 ( 1,291 ) - 1,401 2.9 Patents 803 ( 213 ) ( 8 ) 582 784 ( 217 ) ( 8 ) 559 17.5 Content library 592 ( 138 ) - 454 592 ( 123 ) - 469 7.7 Total $ 151,086 $ ( 64,575 ) $ ( 4,731 ) $ 81,780 $ 171,789 $ ( 76,190 ) $ ( 4,731 ) $ 90,868 F inite-lived intangible assets are stated at cost, net of amortization, generally using the straight-line method over the expected useful lives of the intangible assets. Amortization of intangible assets, excluding developed technology, was $ 2,685 and $ 2,814 for the three months ended March 31, 2024 and 2023, respectively. Amortization of developed technology was recorded as part of cost of revenues in the amount of $ 765 and $ 1,316 for the three months ended March 31, 2024 and 2023, respectively. The expected future amortization expense for intangible assets as of March 31, 2024 is as follows: 2024 (remainder) $ 8,800 2025 10,441 2026 10,183 2027 9,774 2028 9,427 Thereafter 33,155 Total $ 81,780 Capitalized software development costs Capitalized software development costs are as follows. March 31, 2024 December 31, 2023 Gross Carrying Amount Accumulated Amortization Accumulated Impairment Net Gross Carrying Amount Accumulated Amortization Impairment Net Capitalized software development costs $ 27,008 $ ( 11,754 ) $ ( 1,492 ) $ 13,762 $ 27,659 $ ( 12,795 ) $ ( 1,492 ) $ 13,372 During the three months ended March 31, 2024 and 2023, the Company capitalized interest on capitalized software development costs in the amount of $ 132 and $ 117 , respectively. Amortization of capitalized software development costs was recorded as part of cost of revenues in the amount of $ 1,663 and $ 1,281 for the three months ended March 31, 2024 and 2023 , respectively. The estimated useful life is determined at the time each project is placed in service.

Goodwill

Goodwill	3 Months Ended
	Mar. 31, 2024
Goodwill [Roll Forward]
Goodwill	7. Goodwill Goodwill represents the excess of the purchase price in a business combination over the fair value of net assets acquired. Goodwill amounts are not amortized, but are rather tested for impairment at least annually as of October 1 of each year. The changes in the carrying amounts of goodwill, which are generally not deductible for tax purposes, are as follows: Balance at December 31, 2023 $ 187,703 Sale of Board.org ( 23,022 ) Impact of foreign currency fluctuations ( 347 ) Balance at March 31, 2024 $ 164,334 Due to the decline in the Company’s stock price and market capitalization in the first quarter of 2023, and the underperformance of the Company’s ESG reporting unit compared to internal projections, the Company performed a quantitative goodwill impairment assessment as of March 31, 2023. This quantitative assessment resulted in all the goodwill in our ESG reporting unit being impaired; accordingly, an impairment charge of $ 5,837 was recognized during the three months ended March 31, 2023. Prior to the quantitative goodwill impairment the Company tested the recoverability of its long-lived assets, and concluded that such assets were not impaired. The fair value estimate of the Company's reporting units was derived based on an income approach. Under the income approach, the Company estimated the fair value of reporting units based on the present value of estimated future cash flows, which the Company considers to be a Level 3 unobservable input in the fair value hierarchy. The Company prepared cash flow projections based on management's estimates of revenue growth rates and operating margins, taking into consideration the historical performance and the current macroeconomic, industry, and market conditions. The Company based the discount rate on the weighted-average cost of capital considering Company-specific characteristics and the uncertainty related to our reporting unit's ability to execute on the projected cash flows. Potential indicators of impairment include significant changes in performance relative to expected operating results, significant negative industry or economic trends, or a significant decline in the Company's stock price and/or market capitalization for a sustained period of time. It is reasonably possible that one or more of these impairment indicators could occur or intensify in the near term, which may result in an impairment of long-lived assets or further impairment of goodwill.

Debt

Debt	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Debt	8. Debt The following presents the carrying value of the Company’s debt as of the respective period ends: March 31, 2024 December 31, 2023 Senior Term Loan $ 92,891 $ 158,228 New GPO Note 33,252 36,954 Convertible Notes 14,557 14,052 Dragonfly Seller Convertible Notes 7,857 9,002 Era Convertible Note 8,461 5,977 Aicel Convertible Note 1,114 1,156 PPP loan 117 144 Total gross debt 158,249 225,513 Debt issuance costs ( 5,220 ) ( 3,098 ) Total 153,029 222,415 Less: Current portion ( 67 ) ( 105 ) Total $ 152,962 $ 222,310 Senior Term Loan On July 29, 2022, concurrent with the closing of the Company's Business Combination, FiscalNote, Inc., a wholly owned indirect subsidiary of FiscalNote Holdings, Inc., entered into a senior credit agreement (the "Credit Agreement") providing for a Senior Term Loan consisting of a fully funded principal amount of $ 150,000 and an uncommitted incremental loan facility totaling $ 100,000 available upon notice if the Company meets certain financial growth criteria and other customary requirements (the “Incremental Term Facility”) (collectively the “Senior Credit Facility”). The annual interest of the Senior Term Loan consists of two components: a cash interest component of (a) the greater of (i) Prime Rate plus 5.0 % per annum or (ii) 9.0 % payable monthly, and (b) interest payable in kind component of 1.00 % per annum, payable in kind monthly. The Senior Credit Facility will mature on July 29, 2027 . On March 17, 2023, the Company entered into Amendment No. 1 (“Amendment No. 1”) to the Credit Agreement dated July 29, 2022. Among other things, Amendment No. 1 provided for the extension of an incremental term loan by one of the lenders under the facility in the principal amount of $ 6,000 which was received by the Company on March 31, 2023, on the same terms as the existing term loans (the “Incremental Facility”). In connection with the funding of the Incremental Facility, t he Company issued the lender warrants expiring July 15, 2027 , to purchase up to 80,000 Class A Common Stock at an exercise price of $ 0.01 per share, in a transaction exempt from registration under the Securities Act of 1933, as amended, in reliance on Regulation D promulgated thereunder. The lender warrants represented a non-cash financing activity. On May 16, 2023, the Company entered into Amendment No. 2 ("Amendment No. 2") to the Credit Agreement dated July 29, 2022. Among other things, Amendment No. 2 joined Dragonfly Eye Limited and Oxford Analytica Limited (“Oxford Analytica”), each a wholly owned subsidiary of the Company, as Guarantors under the Credit Agreement. On August 3, 2023, the Company entered into Amendment No. 3 ("Amendment No. 3") to the Credit Agreement dated July 29, 2022. Among other things, Amendment No. 3 provided for: (a) the extension of the July 2023 Deferred Fee from July 29, 2023 to July 29, 2024, (b) the increase of the July 2023 Deferred Fee from $ 1,734 to $ 2,034 , (c) an increase of the Restatement Date Final Agreement from $ 7,410 to $ 8,970 and (d) the revision to the minimum annual recurring revenue ("ARR") and adjusted EBITDA covenants (as both are defined in the Credit Agreement). In connection with the completion of the sale of Board.org on March 11, 2024, the Company also entered into Amendment No. 4 to the Credit Agreement (the “Amendment No. 4”), pursuant to which, among other things, the lenders consented to the release of the liens on Board.org’s assets and permitted the consummation of the sale in exchange for the permanent prepayment of $ 65,700 of term loans under the Credit Agreement. The Company also made a payment of $ 1,314 and $ 5,754 of related prepayment and exit fees, respectively. Amendment No. 4 also requires that upon receipt of any earn-out payment pursuant to the equity purchase agreement underlying the sale of Board.org, the Company will prepay outstanding obligations under the Credit Agreement in an amount equal to 70 % of the net proceeds received from such earn-out payment, together with a prepayment fee and an exit fee, equal to 5.75 % of the amount of such prepayment. In addition, Amendment No. 4 extended the commencement of amortization payments under the Credit Agreement from August 15, 2025 to August 15, 2026, with such payments to fully amortize the term loans by the maturity date of July 15, 2027 . Amendment No. 4 also increased the Company’s minimum liquidity covenant to $ 22,500 and modified the Company’s minimum ARR and adjusted EBITDA (as defined in the Credit Agreement, as amended) in order to appropriately reflect the sale of Board.org and the absence of its future contributions to the Company’s overall financial performance and position. The Prime Rate in effect for the Senior Term Loan was 8.50 % at March 31, 2024. For the three months ended March 31, 2024, the Company incurred $ 4,911 of cash interest and $ 364 of paid-in-kind interest, respectively, on the Senior Term Loan. Paid-in-kind interest is reflected as a component of the carrying value of the Senior Term Loan as the payment of such interest will occur upon the settlement of the Senior Term Loan. The Company may prepay the Senior Term Loan in whole, subject to a 2.0 % prepayment fee if prepaid prior to July 30, 2024, 1.0 % prepayment fee if prepaid after July 30, 2024 but prior to July 30, 2025, and no prepayment fee if prepaid on or after July 30, 2025. The July 2023 Deferred Fee, as previously amended, of $ 2,034 was paid as part of Amendment No. 4. Accordingly, the Company recognized the accretion of the July 2023 Deferred Fee as interest expense through March 11, 2024. Prior to Amendment No. 4, the Company had $ 8,970 of deferred fees due at the earlier of prepayment or maturity of the Senior Term Loan which were amortized over the term of the Senior Term Loan using the effective interest method. On March 11, 2024, and as a result of Amendment No. 4, the Company had $ 5,250 of deferred fees outstanding which the Company recognized the accretion of these deferred fees as interest expense. The $ 1,134 of prepayment fee paid on March 11, 2024 was treated as a debt discount. The amortization recorded for the three months ended March 31, 2024 and March 31, 2023 is $ 646 a nd $ 149 , respectively, and is included within interest expense in the condensed consolidated statements of operations and comprehensive income (loss). The remaining unamortized debt discount at March 31, 2024 is $ 4,629 , excluding any deferred fees, and is reflected net against debt on the condensed consolidated balance sheets. The Senior Term Loan is senior to all other debt and has a first priority lien on substantially all of the Company’s assets. The Senior Term Loan contains customary negative covenants related to borrowing, events of default and covenants, including certain non-financial covenants and covenants limiting the Company’s ability to dispose of assets, undergo a change in control, merge with or acquire stock, and make investments, in each case subject to certain exceptions. In addition to the negative covenants, there were four financial covenants in place at March 31, 2024 : a minimum cash balance requirement, minimum ARR requirement, an adjusted EBITDA requirement and a capital expenditure limitation. As of, and for the three months ended March 31, 2024, the Company was in compliance with all required financial covenants. Upon the occurrence of an event of default, in addition to the lenders being able to declare amounts outstanding under the Senior Term Loan due and payable the lenders can elect to increase the interest rate by 5.0 % per annum. New GPO Note On June 30, 2023 (the “Subscription Date”), the Company entered into an Exchange and Settlement Agreement (the “Exchange and Settlement Agreement”) with GPO FN Noteholder LLC (the “Investor”) pursuant to which (i) the Investor returned 5,881,723 shares of Class A Common Stock held by the Investor to the Company for cancellation, (ii) the Company issued to the Investor a subordinated convertible promissory note in an initial principal amount of $ 46,794 (the “New GPO Note”), and (iii) the parties agreed to a mutual settlement and release of all claims including, but not limited to, any claims by the Investor for additional shares or money damages resulting from the entry into the Merger Agreement, relating to or arising from the conversion of the Amended and Restated Senior Secured Subordinated Promissory Note, dated December 29, 2020, previously issued by a subsidiary of the pre-business combination FiscalNote Holdings, Inc. to the Investor. The exchange and settlement are non-cash exchanges in the condensed consolidated statement of cash flows. The before mentioned transactions closed on July 3, 2023. The New GPO Note will mature on July 3, 2028 , unless earlier redeemed or repurchased by the Company or converted in accordance with the terms thereof. The New GPO Note bears interest at a rate of 7.50 % per annum payable quarterly in arrears, as follows: (i) for the first year following the date of issuance, interest will be payable in kind by adding interest to the principal amount of the New GPO Note; and (ii) for any period thereafter, interest will be payable in cash or freely tradeable shares of Class A Common Stock, at the Company’s option, with the value per share determined with reference to the trailing 30-day volume weighted average trading price prior to the interest payment date, subject to certain exceptions under which the Company will be permitted to pay PIK Interest. The New GPO Note is subordinate to the Company’s obligations under its Senior Term Loan which limits certain actions that the Company and the Investor may take under the New GPO Note. At any time prior to the July 3, 2028, the Investor is entitled to convert all or any portion of the principal amount of the New GPO Note and accrued interest thereon into shares of Class A Common Stock at $ 8.28 per share (adjusted to $ 6.89 on April 11, 2024 pursuant to the terms of the New GPO Note as a result of the issuance of the Additional Fee Shares to Era as described in Note 18, "Subsequent Events"). The New GPO Note is subject to customary anti-dilution adjustments for stock sp lits and similar transactions and, subject to standard exceptions, weighted average anti-dilution protection. The principal amount, together with accrued interest thereon, of the New GPO Note is redeemable by the Company in whole or in part based on certain conditions as defined in the New GPO Note. The Company elected to account for the New GPO Note using the fair value option. The New GPO Note was recorded at its June 30, 2023 acquisition date fair value of $ 36,583 . The Company initially recorded a loss contingency of $ 11,700 in its fiscal year 2022 financial statements representing the difference between the fair value of the shares returned by the Investor and the fair value of the New GPO Note on the date of exchange. With the execution of the Exchange and Settlement Agreement and New GPO Note, the Company recorded an additional non-cash loss on settlement with GPO of $ 3,474 in the condensed consolidated statement of operations for the year ended December 31, 2023. The fair market value at March 31, 2024 and December 31, 2023 was $ 33,252 and $ 36,954 , respectively. The unrealized change in the fair value of the New GPO Note of $ 4,443 is recorded in accumulated other comprehensive income for the period ended March 31, 2024 and the non-cash gain of $ 180 was recorded in the change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss) during the three months ended March 31, 2024. The Company incurred total interest expense related to the new GPO note of $ 921 for the three months ended March 31, 2024. Convertible Notes At March 31, 2024 , the holders of four convertible notes that were previously issued by Old FiscalNote (the “Convertible Notes”) with a principal and accrued PIK balance of $ 14,557 remain outstanding. The Company incurred total interest expense related to the Convertible Notes, including the amortization of the various discounts, of $ 598 and $ 515 during the three months ended March 31, 2024 and 2023, respectively. Dragonfly Seller Convertible Notes In connection with the Company's acquisition of Dragonfly, the Company financed part of the purchase with the issuance of convertible notes. The Dragonfly Convertible Notes were issued in a principal amount of £ 8.9 million pounds sterling (approximately $ 11,050 on the closing date of the acquisition), with interest at an annual rate of 8 %, which can be paid in cash or paid-in-kind. The paid-in-kind interest will be annually credited to the principal amount. All principal and accrued interest are due upon maturity on January 27, 2028 . At any time after August 2, 2023, the Company can convert any portion of the principal and accrued interest at the volume weighted-average price for the five consecutive trading day period ending on the last trading day of the calendar month preceding the date the Company provides notice of conversion to the Sellers. At any time after the 18 month anniversary of the Dragonfly acquisition closing date, the lender has the right to convert the outstanding principal and accrued interest for FiscalNote common stock at $ 10.00 per share, subject to adjustment in the event of any stock dividend, stock split, reverse stock split, combination or other similar recapitalization with respect to common stock. The Company elected to account for the Dragonfly Seller Convertible Notes using the fair value option. The Dragonfly Seller Convertible Notes were recorded at their acquisition date fair value of $ 8,635 . The fair market value at March 31, 2024 and at December 31, 2023 was $ 7,857 and $ 9,002 . The unrealized change in the fair value of the Dragonfly Seller Convertible Note of $ 1,264 is recorded in accumulated other comprehensive income for the period ended March 31, 2024 and the non-cash gain of $ 47 was recorded in the change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss) during the three months ended March 31, 2024 and a non-cash gain of $ 574 is recorded in the change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss) during the three months ended March 31, 2023, respectively. The Company incurred total interest expense related to the Dragonfly Seller Convertible Notes of $ 241 and $ 153 during the three months ended March 31, 2024 and March 31, 2023, respectively. Era Convertible Notes In connection with the Company’s strategic commercial partnership, the Company issued a convertible note to Era, a third-party lender, dated December 8, 2023 for $ 5,500 on December 8, 2023 (the "Issuance Date"). Pursuant to the terms of the December 8, 2023 convertible note, the Company issued that same third-party lender a second convertible note for $ 801 on January 5, 2024 (collectively, the "Era Convertible Notes"). The Era Convertible Notes were issued in a principal amount of $ 6,301 , with cash interest at a rate equal to the applicable federal rate published by the Internal Revenue Service beginning on the six-month anniversary of the Issuance Date. All principal and unpaid interest are due on maturity at December 8, 2027 . The Era Convertible Notes are contractually subordinated to the Company’s obligations under its senior secured indebtedness, and accordingly, the Company’s right to make certain cash payments in connection therewith is limited by the terms of such subordination agreement (the “Subordination Agreement”). Era may convert the Notes into shares of Common Stock (the “Underlying Shares”), beginning on the six-month anniversary of the Issuance Date based on the volume weighted average price of the trailing 30 trading day period prior to the conversion. In addition, the Company may elect to convert the Era Convertible Notes into the Underlying Shares if the Underlying Shares are registered for resale under the Securities Act of 1933, as amended (the “Securities Act”). Pursuant to the copilot agreement (the "Co-Pilot Agreement") entered into by and among the Company, FiscalNote Inc., a subsidiary of the Company, and Era on December 8, 2023, the Company agreed to issue Era up to an additional $ 3,105,105 in the form of shares of the Company's Class A Common Stock no later than June 2024 (the "Partnership Shares"). The Co-Pilot Agreement requires the Company to issue additional shares of Common Stock (“Additional Shares”) to Era if Era’s sales of the Partnership Shares and the Underlying Shares do not generate aggregate cash proceeds to Era that equal or exceed approximately $ 9.5 million during the sell-off period set forth in the Co-Pilot Agreement. Any such Additional Shares would be valued based on the volume weighted average price of the trailing 30 trading day period, calculated prior to the date of any such issuance. The Company elected to account for the Era Convertible Notes using the fair value option. The Era Convertible Note dated December 8, 2023 was recorded at its acquisition date fair value of $ 5,500 . The Era Convertible Note Dated January 5, 2024 was recorded at its acquisition date fair value of $ 801 . The fair market value of the Era Convertible Note dated December 8, 2023 was $ 5,977 at December 31, 2023. The fair market value of the two Era Convertible Notes was $ 8,461 at March 31, 2024. The non-cash loss was recorded in the change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss) in the amount of a loss of $ 1,683 for the three months ended March 31, 2024. Aicel Convertible Note In connection with the Company’s acquisition of Aicel, the Company assumed a convertible note (“Aicel Convertible Note”) issued by Aicel in a private placement to a third-party lender dated July 27, 2022. The Aicel Convertible Note was issued in a principal amount of $ 1,131 , with paid-in-kind interest at an annual rate of 1 %. All principal and accrued and unpaid interest are due on maturity at July 27, 2027 . The Aicel Convertible Note provides for no prepayments until maturity without written consent of the lender. The Aicel Convertible Note can be converted upon the occurrence of certain events, including (i) Aicel initial public offering (“IPO”), (ii) change in control of Aicel (the acquisition of Aicel by FiscalNote did not constitute a change in control as defined in the purchase agreement), or (iii) sale of substantially all of Aicel’s assets (collectively, a “Conversion Event”). The Company has the right to convert the Aicel Convertible Note into shares of common stock issued in an IPO, if (a) the Conversion Event is an IPO and (b) the price per share paid in an IPO is greater than the stipulated initial conversion price. The lender has the right to elect to convert the Aicel Convertible Note into shares of common stock upon the occurrence of a Conversion Event. At any time after the second anniversary of the Aicel acquisition closing date until the earlier of (a) the Aicel Convertible Note maturity date, or (b) the occurrence of any liquidity event, the lender has the right to require FiscalNote to repurchase the outstanding principal in exchange for FiscalNote common stock. The lender will receive a number of shares of FiscalNote equal to the outstanding principal plus accrued interest divided by the FiscalNote common stock price and rounded to the nearest whole share. Upon the occurrence of an event of default, in addition to the lenders being able to declare amounts outstanding under the Aicel Convertible Note due and payable the lenders can elect to increase the paid-in-kind interest rate to 12.0 % per annum. The Company concluded that the contingent default interest provision was required to be bifurcated and treated as an embedded derivative liability. The associated value was immaterial and required no initial amount to be recorded and continues to be immaterial as of the reporting date . The Company determined that the remaining embedded features were clearly and closely related to the debt host and did not require bifurcation from the debt host. The Aicel Convertible Note was recorded at its acquisition fair value of $ 1,131 . The Company incurred total interest expense related to the Aicel Convertible Note of $ 19 and $ 3 du ring the three months ended March 31, 2024 and March 31, 2023, respectively. PPP Loan On April 13, 2020, the Company received funding in the principal amount of $ 8,000 under the CARES Act. Interest accrues annually at 1 %. On February 14, 2022, the SBA forgave $ 7,667 of the PPP Loan with the remaining balance of $ 333 to be repaid over five years . The Company recognized the forgiveness of PPP Loan as a gain on debt extinguishment in the condensed consolidated statements of operations and comprehensive income (loss) in 2022. As of March 31, 2024, the Company recorded $ 67 of the remaining PPP Loan as short-term debt and $ 50 as lon g-term debt in the condensed consolidated balance sheets. Total Debt The following table summarizes the total estimated fair value of the Company's debt as of March 31, 2024 and December 31, 2023, respectively. These fair values are deemed Level 3 liabilities within the fair value measurement framework. March 31, 2024 December 31, 2023 Senior Term Loan $ 92,497 $ 168,702 New GPO Note 33,252 36,954 Convertible Notes 13,709 13,992 Dragonfly Seller Convertible Notes 7,857 10,407 Era Convertible Notes 8,461 5,977 Total $ 155,776 $ 236,032 Warrants Old FiscalNote Warrants At March 31, 2024, 118,700 warrants (previously issued by Old FiscalNote to lenders prior to the Senior Term Loan) with an exercise price of $ 8.56 , remain outstanding. These warrants are accounted for as a liability with a fair value of $ 0 at March 31, 2024, and are included as part of the other non-current liabilities within the condensed consolidated balance sheets. Warrants associated with Amendment No. 1 On March 17, 2023, in connection with Amendment No. 1 discussed above, the Company issued 80,000 warrants with an exercise price of $ 0.01 . These warrants are accounted for as a liability with a fair value of $ 106 at March 31, 2024 , and are included as part of the other non-current liabilities within the condensed consolidated balance sheets.

Stockholders' Equity

Stockholders' Equity	3 Months Ended
	Mar. 31, 2024
Stockholders' Equity Note [Abstract]
Stockholders’ Equity	9. Stockholders’ Equity Authorized Capital Stock The Company’s charter authorizes the issuance of 1,809,000,000 shares, which includes Class A common stock, Class B common stock, and preferred stock. Class A Common Stock Subsequent to the Closing of the Business Combination, the Company's Class A common stock and public warrants began trading on the New York Stock Exchange (“NYSE”) under the symbols “NOTE” and “NOTE WS,” respectively. Pursuant to the Company’s charter, the Company is authorized to issue 1,700,000,000 shares of Class A common stock, par value $ 0.0001 per share. As of March 31, 2024, the Company had 122,749,497 shares of C lass A common stock issued and outstanding. Additionally, the Company has outstanding warrants to purchase shares of New FiscalNote Class A common stock that became exercisable upon the Closing of the Business Combination. Refer to Note 11, "Warrant Liabilities." Class B Common Stock Pursuant to the Company’s charter, the Company is authorized to issue 9,000,000 shares of Class B common stock, par value $ 0.0001 per share. In connection with the Closing of the Business Combination, the Co-Founders, or entities controlled by the Co-Founders, received Class B shares of New FiscalNote common stock as consideration (see further details in Note 2, "Business Combination with DSAC"). As of March 31, 2024 , the Company had 8,290,921 shares of Class B common stock issued and outstanding. Preferred Stock Pursuant to the Company’s charter, the Company is authorized to issue 100,000,000 shares of preferred stock, par value $ 0.0001 per share. Our board of directors has the authority without action by the stockholders, to designate and issue shares of preferred stock in one or more classes or series, and the number of shares constituting any such class or series, and to fix the voting powers, designations, preferences, limitations, restrictions and relative rights of each class or series of preferred stock, including, without limitation, dividend rights, conversion rights, redemption privileges and liquidation preferences, which rights may be greater than the rights of the holders of the common stock. As of March 31, 2024 , there were no shares of preferred stock issued and outstanding. Dividends The Company's Class A and Class B common stock are entitled to dividends if and when any dividend is declared by the Company's board of directors, subject to the rights of all classes of stock outstanding having priority rights to dividends. The Company has not paid any cash dividends on common stock to date. The Company may retain future earnings, if any, for the further development and expansion of the Company's business and have no current plans to pay cash dividends for the foreseeable future. Any future determination to pay dividends will be made at the discretion of the Company's board of directors and will depend on, among other things, the Company's financial condition, results of operations, capital requirements, restrictions contained in future agreements and financing instruments, business prospects and such other factors as the Company's board of directors may deem relevant.

Earnout Shares and RSUs

Earnout Shares and RSUs	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Earnout Shares and RSUs	10. Earnout Shares and RSUs The shareholders and other equity holders of Old FiscalNote as described below are entitled to receive up to 19,195,100 additional shares of Class A common stock of New FiscalNote (the “Earnout Awards”) in the form of Earnout Shares or as shares reserved for issuances upon settlement of Earnout RSUs, as described below. The Earnout Awards are split into five tranches each consisting of 3,839,020 shares of Class A common stock in New FiscalNote. Certain Old FiscalNote equity holders will receive Earnout Restricted Stock Units (the “Earnout RSUs”), which are settled in Class A common stock. The right to receive Earnout Awards will expire five years after the Closing Date (the “Earnout Period”). Each tranche of the Earnout Awards will be issued only when the dollar volume-weighted average price of one share of New FiscalNote Class A common stock is greater than or equal to $ 10.50 , $ 12.50 , $ 15.00 , $ 20.00 , or $ 25.00 , respectively, for any 10 trading days within any period of 20 consecutive trading days during the Earnout Period (collectively, the “Triggering Events”). Pursuant to the terms of the Business Combination Agreement, the holders of Old FiscalNote common stock, Old FiscalNote warrants, vested Old FiscalNote options and vested Old FiscalNote RSUs outstanding immediately prior to the Closing Date will be entitled to receive their proportionate allocation of Earnout Shares subject to achievement of the Triggering Event. Holders of unvested Old FiscalNote options and unvested Old FiscalNote RSUs outstanding immediately prior to the Closing Date will be entitled to receive their proportionate allocation of Earnout Shares in the form of Earnout RSUs subject to achievement of the Triggering Event. To the extent the equity award issued upon New FiscalNote's assumption of such any Old FiscalNote Option or Old FiscalNote RSU (each a “Converted Award”) is outstanding and has vested as of the occurrence of a Triggering Event, the holder thereof will receive a proportionate allocation of Earnout Shares in lieu of Earnout RSUs. If a Converted Award is forfeited after the Closing Date but prior to the Triggering Event, no Earnout RSUs will be issued for such Converted Award. The right to receive Earnout RSUs that have been forfeited shall be reallocated pro-rata to the remaining holders of vested Converted Awards in the form of Earnout Shares and unvested Converted Awards in the form of Earnout RSUs in the manner described above. Reallocated Earnout RSUs are subject to the remaining vesting schedule and conditions of the Converted Award held by such equity holder. The forfeiture and subsequent reallocation of the Earnout RSUs are accounted for as the forfeiture of the original award and the grant of a new award. A portion of the Earnout Shares that may be issued to Old FiscalNote common stockholders, Old FiscalNote vested option holders and Old FiscalNote warrant holders and all of the Earnout RSUs were determined to represent additional compensation for accounting purposes pursuant to ASC 718, “Compensation-Stock Compensation”. The Company recognizes stock-compensation expense based on the fair value of the Earnout Awards over the requisite service period for each tranche. Upon Closing, the Company recognized $ 17,712 of share-based compensation expense for vested Earnout Awards. The Company recognized $ 131 and $ 1,124 of s hare-based compensation expense during the three months ended March 31, 2024 and March 31, 2023, respectively. The remaining Earnout Shares were determined to represent an equity transaction in conjunction with the reverse recapitalization and were evaluated pursuant to ASC 480, “Distinguishing Liabilities from Equity” and ASC 815, “Derivatives and Hedging”. These remaining Earnout Shares will be accounted for as a liability as the arrangement is indexed to something other than the Company’s stock. The liability is revalued at each reporting period with changes being recorded as a non-operating gain or loss in the condensed consolidated statements of operations and comprehensive income (loss). The liability of $ 68 was recorded in other non-current liabilities on the condensed consolidated balance sheets as of March 31, 2024 and December 31, 2023. As of March 31, 2024, there was $ 546 of u nrecognized compensation expense related to the Earnout Awards to be recognized over a weighted-average period of approximately one and a half years . As of March 31, 2024, no Earnout Shares and no Earnout RSUs have been issued as no Triggering Events have occurred.

Warrant Liabilities

Warrant Liabilities	3 Months Ended
	Mar. 31, 2024
Warrants and Rights Note Disclosure [Abstract]
Warrant Liabilities	11. Warrant Liabilities Upon the Closing of the Business Combination, the Company assumed 8,750,000 public warrants and 7,000,000 private placement warrants that were previously issued by Old DSAC. Each public warrant and private placement warrant is exercisable for 1.571428 shares of New FiscalNote Class A common stock (or an aggregate of up to 24,750,000 shares of New FiscalNote Class A common stock). During the three months ended March 31, 2024 , no public warrants were exercised into shares of Class A common stock. No private placement warrants have been exercised to date. Accordingly, as of March 31, 2024, the Company had 8,358,964 public warrants and 7,000,000 private placement warrants outstanding with a per share fair value of $ 0.44 . These warrants are accounted for as a liability and have a fair value of $ 3,840 at March 31, 2024. Public Warrants Each public warrant entitles the registered holder to acquire 1.571428 shares of the Company’s Class A common stock at a price of $ 7.32 per share, subject to adjustment as discussed below. The warrants became exercisable on August 29, 2022. Warrants may only be exercised for a whole number of shares of Class A common stock. The public warrants will expire on July 29, 2027 , or earlier upon redemption or liquidation. Redemption of warrants for cash The Company may call the public warrants for redemption for cash: • in whole and not in part; • at a price of $ 0.01 per warrant; • upon a minimum of 30 days ’ prior written notice of redemption to each warrant holder; and • if, and only if, the last reported sale price of the Company’s Class A common stock equals or exceeds $ 11.45 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like and for certain issuances of the Company’s Class A common stock and equity-linked securities) for any 20 trading days within a 30 -trading day period ending on the third trading day prior to the date the Company sends the notice of redemption to the warrant holders. If and when the warrants become redeemable by the Company for cash, the Company may exercise its redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of warrants for shares of Class A common stock The Company may redeem the outstanding warrants for shares of Class A common stock: • in whole and not in part; • at $ 0.10 per warrant upon a minimum of 30 days ’ prior written notice of redemption provided that holders will be able to exercise their warrants prior to redemption and receive that number of shares determined by reference to an agreed table, based on the redemption date and the “fair market value” of Class A common stock (as defined below) except as otherwise described below; • if, and only if, the last reported sale price of the Company’s Class A common stock equals or exceeds $ 6.36 per share (as adjusted per stock splits, stock dividends, reorganizations, recapitalizations and the like and for certain issuances of the Company’s Class A common stock and equity-linked securities) on the trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and • if and only if, the private placement warrants are also concurrently exchanged at the same price (equal to a number of shares of our Class A common stock) as the outstanding public warrants, as described above. • The “fair market value” of the Class A common stock shall mean the average of the last reported sales price for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. In no event will the warrants be exercisable in connection with this redemption feature for more than 0.567 shares of Class A common stock per warrant (subject to adjustment). Private Placement Warrants The private placement warrants are not redeemable by the Company so long as they are held by the sponsor of DSAC or its permitted transferees, except in certain limited circumstances. The DSAC Sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis and the DSAC Sponsor and its permitted transferees has certain registration rights related to the private placement warrants (including the shares of Class A common stock issuable upon exercise of the private placement warrants). Except as described in this section, the private placement warrants have terms and provisions that are identical to those of the public warrants. If the private placement warrants are held by holders other than the DSAC Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the public warrants.

Stock-Based Compensation

Stock-Based Compensation	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Stock-Based Compensation	12. Stock-Based Compensation 2022 Long-Term Incentive Plan In connection with the Business Combination, the Company's board of directors adopted, and its stockholders approved, the 2022 Long-Term Incentive Plan (the “2022 Plan”) under which 20,285,600 shares of Class A common stock were initially reserved for issuance. The 2022 Plan allows for the issuance of incentive stock options, non-statutory stock options, stock appreciation rights, restricted stock, restricted stock units, dividend equivalent rights, other stock-based awards and cash-based awards. The number of shares of the Company’s Class A common stock available for issuance under the 2022 Plan increases on the first day of each calendar year, starting on January 1, 2023 and continuing through and including January 1, 2027, by the lesser of (a) 13,523,734 , (b) three percent ( 3 %) of the total number of shares of Class A Common Stock outstanding on December 31st of the immediately preceding fiscal year or (c) a lesser number determined by the Company’s board of directors prior to January 1 of a given year. In accordance with this provision, on each of January 1, 2023 and January 1, 2024, the number of shares authorized for issuance under the 2022 Plan increased by 3,693,767 and 3,650,394 , respectively. During the three months ended March 31, 2024, the Company issued 1,271,410 stock options and 239,663 restricted stock units. At March 31, 2024 , 7,868,951 stock options, 2,601,649 performance stock options, 5,499,350 restricted stock units, and 75,000 performance based restricted stock units remain outstanding. As of March 31, 2024 , the Company had 4,219,656 shares of Class A common stock available for issuance under the 2022 Plan. The Company recognized $ 5,776 and $ 6,404 of stock-based compensation expense for all long term incentive plans in effect during the three months ended March 31, 2024 and 2023 , respectively. The Company recognized $ 169 of stock-based compensation expense related to acquisition earnouts during the three ended March 31, 2024 and 2023, respectively. 2022 Employee Stock Purchase Plan In connection with the Business Combination, the Company’s board of directors adopted, and its stockholders approved, the 2022 Employee Stock Purchase Plan (the “ESPP”) whereby eligible employees may authorize payroll deductions of up to 15 % of their regular base salary to purchase shares at the lower of 85 % of the fair market value of the common stock on the date of commencement of the offering period or on the last day of the six-month offering period. The plan is defined as compensatory, and accordingly, a stock-based compensation charge of $ 99 and $ 102 was recorded as the difference between the fair market value and the discounted purchase price of the Company's common stock for the three months ended March 31, 2024 and 2023, respectively. The number of shares of Common Stock reserved for issuance under the ESPP will automatically increase on January 1st each year, starting on January 1, 2023 and continuing through and including January 1, 2027, by the lesser of (a) 3,267,760 , (b) one percent ( 1 %) of the total number of shares of all classes of Common Stock outstanding on December 31st of the preceding fiscal year, or (c) a lesser number determined by the Board prior to January 1 of a given year. Pursuant to this provision, on each of January 1, 2023 and January 1, 2024, the number of shares authorized for issuance under the ESPP increased by 1,231,255 and 1,299,707 , respectively. During the three months ended March 31, 2024 , 202,327 shares have been issued under the ESPP and the Company had 5,493,588 shares of Class A common stock available for issuance under the ESPP. Withholding Taxes on Equity Awards In connection with the settlement of equity awards, the Company records a non-cash liability and corresponding APIC adjustment for the withholding taxes on net share settlement of stock-based compensation and option exercises until such time as those taxes have been remitted to the respective taxing authorities.

Transaction (Gains) Costs, net

Transaction (Gains) Costs, net	3 Months Ended
	Mar. 31, 2024
Transaction Costs Gains [Abstract]
Transaction (Gains) Costs, net	13. Transaction (Gains) Costs, net The Company incurred the following transaction costs related to businesses acquired and the consummation of the Business Combination during the periods presented: Three Months Ended March 31, 2024 2023 Transaction costs related to acquired businesses $ - $ 1,222 Non-capitalizable Business Combination costs - 184 Change in contingent consideration liabilities ( 4 ) ( 156 ) Contingent compensation expense - 158 Total transaction (gains) costs, net $ ( 4 ) $ 1,408

Earnings (Loss) Per Share

Earnings (Loss) Per Share	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Earnings (Loss) Per Share	Note 14. Earnings (Loss) Per Share The Company has two classes of common stock authorized: Class A common stock and Class B common stock. The rights of the holders of Class A and Class B common stock are identical, except with respect to voting. Each share of Class A common stock is entitled to one vote per share and each share of Class B common stock is entitled to twenty-five votes per share. The Company allocates undistributed earnings attributable to common stock between the common stock classes on a one‑to‑one basis when computing net loss per share. As a result, basic and diluted net income (loss) per share of Class A common stock and Class B common stock are equivalent. The following is a calculation of the basic and diluted earnings per share for the Company's common stock, including a reconciliation between net income attributable to common stockholders used for Basic EPS and Diluted EPS for the three months ended March 31, 2024 and 2023: (in thousands, except per share data) Three Months Ended March 31, 2024 2023 Basic Earnings Per Share Numerator: Net income (loss) attributable to common stockholders $ 50,599 $ ( 19,273 ) Denominator: Weighted average common stock outstanding used in basic EPS computations 130,712,032 133,082,639 Basic Earnings Per Share $ 0.39 $ ( 0.14 ) Diluted Earnings Per Share Numerator: Net income (loss) attributable to common stockholders $ 50,599 $ ( 19,273 ) If-converted impact on net income (loss) attributable to common stockholders 3,673 - Net income (loss) attributable to common stockholders for diluted EPS $ 54,272 $ ( 19,273 ) Denominator: Weighted average common stock outstanding used in basic EPS computations 130,712,032 133,082,639 Weighted average effect of dilutive securities 15,315,053 - Weighted average common stock outstanding used in diluted EPS computations 146,027,085 133,082,639 Diluted Earnings Per Share $ 0.37 $ ( 0.14 ) Since the Company was in a net loss position during the three months ended March 31, 2023, basic net loss per share attributable to common stockholders is the same as diluted net loss per share as the inclusion of all potential common shares outstanding would have been anti-dilutive. Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: Three Months Ended March 31, Anti-dilutive securities excluded from diluted loss per share: 2024 2023 Anti-dilutive Earnout Awards 19,195,100 19,195,100 Anti-dilutive stock options - 2,033,574 Anti-dilutive Convertible Notes - 2,075,225 Anti-dilutive contingently issuable shares - 1,339,924 Anti-dilutive restricted stock units 5,569,966 7,022,744 Anti-dilutive Aicel Convertible Notes - 112,899 Total anti-dilutive securities excluded from diluted loss per share 24,765,066 31,779,466

Provision (Benefit) from Income

Provision (Benefit) from Income Taxes	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Provision (Benefit) from Income Taxes	15. Provision (Benefit) from Income Taxes Effective Tax Rate The Company computes its quarterly and year-to-date provisions for income taxes by applying the estimated effective tax rates to the quarterly and year-to-date pre-tax income or losses and adjusting the provisions for discrete tax items recorded in the periods. For the three months ended March 31, 2024 the Company reported tax expense of $ 1,426 on pre-tax income of $ 52,025 , which resulted in an effective tax rate of 2.74 percent. The Company’s effective tax rate differed from the U.S. statutory rate of 21 percent primarily due to the impact of a valuation allowance on the Company’s deferred tax assets . During the three months ended March 31, 2024 , the Company recorded a discrete tax charge for the impact of the sale of Board.org of $ 1,729 . For the three months ended March 31, 2023, the Company reported tax expense of $ 30 on a pre-tax loss of $ 19,243 , which resulted in an effective tax rate of ( 0.16 ) percent . The Company's effective tax rate differed from the U.S. statutory rate of 21 percent primarily due to the impact of a valuation allowance on the Company’s deferred tax assets . During the three months ended March 31, 2023, the Company had discrete items relating to goodwill impairment, unrecognized tax benefits and the tax impact of interest expense on unrecognized tax benefits. Unrecognized Tax Benefits and Other Considerations The Company records liabilities related to its uncertain tax positions. Tax positions for the Company and its subsidiaries are subject to income tax audits by multiple tax jurisdictions throughout the world. The Company believes that it has provided adequate reserves for its income tax uncertainties in all open tax years. As the outcome of the tax audits cannot be predicted with certainty, if any issues arising in the Company's tax audits progress in a manner inconsistent with management's expectations, the Company could adjust its provision for income taxes in the future. For the three months ended March 31, 2024 , the Company reported an uncertain tax position totaling $ 639 relating to a state tax filing position. The Company has the following activities relating to unrecognized tax benefits for the periods presented: Beginning balances at December 31, 2023 and 2022 $ 639 $ 639 Lapses in statutes of limitations - - Ending balances at March 31, 2024 and 2023 $ 639 $ 639

Fair Value Measurements and Dis

Fair Value Measurements and Disclosures	3 Months Ended
	Mar. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements and Disclosures	16. Fair Value Measurements and Disclosures The carrying value of cash and cash equivalents (including investments with an original maturity of three months or less at the date of purchase), restricted cash, accounts receivable, accounts payable, and other accruals readily convertible into cash approximate fair value because of the short-term nature of the instruments. The following table presents the Company’s financial assets and liabilities accounted for at fair value on a recurring basis as of March 31, 2024 by level within the fair value hierarchy: Level 1 Level 2 Level 3 Total Assets: Cash equivalents $ 3,157 $ - $ - $ 3,157 Short-term investments - 7,134 - 7,134 Liabilities: Public warrants $ 2,090 $ - $ - $ 2,090 Private placement warrants - 1,750 - 1,750 Contingent liabilities from acquisitions - - 113 113 New GPO Note - - 33,252 33,252 Dragonfly Seller Convertible Notes - - 7,857 7,857 Era Convertible Note - - 8,461 8,461 The following table presents the Company’s financial assets and liabilities accounted for at fair value on a recurring basis as of December 31, 2023 by level within the fair value hierarchy: Level 1 Level 2 Level 3 Total Assets: Cash equivalents $ 3,044 $ - $ - $ 3,044 Short-term investments - 7,134 - 7,134 Liabilities: Public warrants $ 2,591 $ - $ - $ 2,591 Private placement warrants - 2,170 - 2,170 Contingent liabilities from acquisitions - - 130 130 Liability classified warrants (a) - - 23 23 New GPO Note - - 36,954 36,954 Dragonfly Seller Convertible Notes - - 9,002 9,002 Era Convertible Note - - 5,977 5,977 (a) - Included in other non-current liabilities on the condensed consolidated balance sheets The following table summarizes changes in fair value of the Company’s level 3 liabilities during the periods presented : Contingent Liability Classified Warrants New GPO Note Dragonfly Seller Convertible Notes Era Convertible Note Balance at December 31, 2023 $ 130 $ 23 $ 36,954 $ 9,002 $ 5,977 Fair value at issuance date - - - - 801 Change in fair value included in the determination of net (income) loss (a) ( 3 ) ( 23 ) ( 180 ) ( 47 ) 1,683 Change in fair value included in accumulated other comprehensive income - - ( 4,443 ) ( 1,264 ) - Cash contingent consideration earned and subsequently settled ( 14 ) - - - - Paid in kind interest - - 921 241 - Foreign exchange - - - ( 75 ) - Balance at March 31, 2024 $ 113 $ - $ 33,252 $ 7,857 $ 8,461 (a) The change in contingent liabilities from acquisitions is recorded as transaction costs on the condensed consolidated statements of operations and comprehensive income (loss). Short-Term Investments The fair value of the short-term investments is based on the quoted market price of the securities on the valuation date. As of March 31, 2024, the estimated fair value of the short-term investments was $ 7,134 . The Company recognized a non-cash loss of $ 49 for the three months ended March 31, 2024 resulting from the change in fair value of the short-term investments. The change in fair value is recorded in the condensed consolidated statements of operations and comprehensive income (loss). Public Warrants The fair value of the public warrants is based on the quoted market price of such warrants on the valuation date. As of March 31, 2024 and December 31, 2023, the estimated fair value of the public warrants was $ 2,090 and $ 2,591 , respectively. The Company recognized a non-cash gain of $ 501 and $ 7,607 during the three months ended March 31, 2024 and 2023, respectively, resulting from the change in fair value of the public warrants. The change in fair value is recorded in change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss). Private Placement Warrants As of March 31, 2024 and December 31, 2023, the estimated fair value of the private warrants was $ 1,750 and $ 2,170 , respectively. The Company recognized a non-cash gain of $ 420 and $ 6,370 during the three months ended March 31, 2024 and March 31, 2023, respectively, resulting from the change in fair value of the private warrants. The change in fair value is recorded in change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss). New GPO Note The New GPO Note was recognized as a liability in connection with the settlement of litigation on June 30, 2023 at its estimated fair value of $ 36,583 . As of March 31, 2024 and December 31, 2023, the estimated fair value of the New GPO Note was $ 33,252 and $ 36,954 , respectively. The unrealized change in the fair value of the New GPO Note of $ 4,443 is recorded in accumulated other comprehensive income for the period ended March 31, 2024 and the non-cash gain of $ 180 was recorded in the change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss) during the three months ended March 31, 2024. The estimated fair value of the New GPO Note was determined based on a trinomial lattice model. The following table presents the assumptions used to determine the fair value of the New GPO Note at March 31, 2024 and at December 31, 2023: March 31, 2024 December 31, 2023 Common stock share price $ 1.33 $ 1.14 Risk free rate 4.3 % 3.9 % Yield 18.5 % 14.5 % Expected volatility 50.0 % 50.0 % Expected term (years) 4.3 4.5 Dragonfly Seller Convertible Notes The Dragonfly Seller Convertible Notes were recognized as a liability in connection with the acquisition on January 27, 2023 at a fair value of $ 8,635 . As of March 31, 2024 and December 31, 2023, the estimated fair value of the Dragonfly Seller Convertible Notes were $ 7,857 and $ 9,002 , respectively . The unrealized change in the fair value of the Dragonfly Seller Convertible Note of $ 1,264 is recorded in accumulated other comprehensive income for the period ended March 31, 2024, a non-cash gain of $ 47 is recorded in the change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss) during the three months ended March 31, 2024 and a non-cash gain of $ 573 is recorded in the change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss) during the three months ended March 31, 2023, respectively. The following table presents the assumptions used to determine the fair value of the Dragonfly Seller Convertible Notes at March 31, 2024 and December 31, 2023: March 31, 2024 December 31, 2023 Common stock share price $ 1.33 $ 1.14 Risk free rate 4.3 % 3.9 % Yield 20.0 % 15.5 % Expected volatility 50.0 % 50.0 % Expected term (years) 3.8 4.1 As of March 31, 2024, the difference between the aggregate fair value and the unpaid principal balance of the Dragonfly Seller Convertible Notes i s $ 4,490 . Era Convertible Note The Era Convertible Note was recognized as a liability associated with the Company’s strategic commercial partnership on December 8, 2023 at a fair value of $ 5,500 . During the first quarter of 2024, the Company issued $ 801 of new debt related to the new Era Convertible Note. At March 31, 2024 and December 31, 2023 the fair value of the Era Convertible Note was $ 8,461 and $ 5,977 , respectively. The non-cash loss of $ 1,684 is recorded in the change in fair value of financial instruments in the condensed consolidated statements of operations and comprehensive income (loss) during the three months ended March 31, 2024. The following table presents the assumptions used to determine the fair value of the Era Convertible Note at March 31, 2024 and December 31, 2023: March 31, 2024 December 31, 2023 Common stock share price $ 1.33 $ 1.14 Risk free rate 4.8 % 4.17 % Yield 156.1 % 153.24 % Expected volatility 51.0 % 63.00 % Expected term (years) 3.7 3.9 Contingent Liabilities from acquisitions The contingent liabilities from acquisitions are clas sified as Level 3 in the fair value hierarchy. At March 31, 2024 and December 31, 2023, the contingent consideration and compensation relates to the following acquisitions: March 31, 2024 December 31, 2023 Curate $ - $ 4 Equilibrium 113 112 DT Global - 14 Total contingent liabilities from acquisitions $ 113 $ 130 The Company settled part of the Curate contingent consideration and compensation through an issuance of 83,393 additional shares in a non-cash transaction during the first quarter of 2023. Liability classified warrants The Last Out Lender Warrants are classified as Level 3 in the fair value hierarchy. The fair value of the Last Out Lender Warrants is calculated using the Black-Scholes calculation with the following inputs: March 31, 2024 Common stock fair value $ 1.33 Time to maturity (years) 1.3 Risk free rate 4.88 % Volatility 52 % Exercise price $ 8.56 Non-Financial Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis The Company’s long-lived assets, including property and equipment, intangible assets and goodwill are measured at fair value on a non-recurring basis when an impairment has occurred. The Company has recognized an impairment of goodwill as disclosed in Note 7, "Goodwill" during the three months ended March 31, 2023. The Company has not identified any additional impairments to be recorded during both the three months ended March 31, 2024 and 2023. There were no other transfers of assets or liabilities between levels during both the three months ended March 31, 2024 and 2023. Changes to fair value are recognized as income or expense in the condensed consolidated statements of operations and comprehensive income (loss).

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	17. Commitments and Contingencies Legal Proceedings From time to time the Company is a party to various disputes, claims, lawsuits and other regulatory and legal matters, including both asserted and unasserted legal claims, in the ordinary course of business. The status of each such matter, referred to herein as a loss contingency, is reviewed and assessed in accordance with applicable accounting rules regarding the nature of the matter, the likelihood that a loss will be incurred, and the amounts involved. Legal fees are recognized as incurred when the legal services are provided, and therefore are not recognized as part of the loss contingency.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	18. Subsequent Events The Company has evaluated subsequent events through May 10, 2024, the date that the financial statements were available to be issued. Era Convertible Note On April 11, 2024, the “Company entered into a letter agreement (the “Letter Agreement”) with Era modifying certain provisions of the Era Convertible Notes and the Co-Pilot Agreement. The Letter Agreement permitted and required the Company to convert approximately $ 1.6 million in aggregate principal amount of the Era Convertible Notes (the “Early Converted Notes”) into a portion of the Underlying Shares. Pursuant to the Letter Agreement, the Company was also required to issue to Era the Partnership Shares. Pursuant to the Letter Agreement, Era has the right to convert the aggregate principal amount of the remaining Era Convertible Notes (the “Remaining Notes”), but only on or after June 30, 2024, if such conversion right is not cancelled by the terms of the Letter Agreement. In addition, the Letter Agreement terminates the Company’s obligation to issue the Additional Shares under the circumstances specified therein. On April 11, 2024 and pursuant to the Letter Agreement, the Company issued the Investor an aggregate of 3,003,268 shares of Common Stock to satisfy its obligations with respect to the Partnership Shares and a portion of the Underlying Shares.

Summary of Business and Signi_2

Summary of Business and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Description of Business	Description of Business FiscalNote Holdings, Inc. (“FiscalNote,” or the “Company”) is a leading technology provider of global policy and market intelligence. It delivers critical, actionable legal and policy insights in a rapidly evolving political, regulatory and macroeconomic environment. By combining artificial intelligence (AI) technology, other technologies with analytics, workflow tools, and expert peer insights, FiscalNote empowers customers to manage policy, address regulatory developments, and mitigate global risk. FiscalNote ingests unstructured legislative and regulatory data, and employs AI and data science to deliver structured, relevant and actionable information in order to facilitate key operational and strategic decisions by global enterprises, midsized and smaller businesses, government institutions, trade groups, and nonprofits. FiscalNote delivers that intelligence through its suite of public policy and issues management products. The Company is headquartered in Washington, D.C.
Principles of Consolidation	Principles of Consolidation The condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All significant intercompany balances have been eliminated in consolidation. These condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information. Accordingly, they do not include all of the financial information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of the Company’s management, the unaudited condensed consolidated financial statements include all adjustments necessary for the fair presentation of the Company’s balance sheet and its results of operations, including its comprehensive loss, temporary equity, stockholders' equity (deficit), and cash flows. All adjustments are of a normal recurring nature. The results for the three months ended March 31, 2024 are not necessarily indicative of the results to be expected for any subsequent quarter or for the fiscal year ending December 31, 2024. These condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2023 .
Liquidity and Going Concern	Liquidity and Going Concern Historically the Company’s cash flows from operations have not been sufficient to fund its current operating model and the Company funded operations through raising equity and debt. The Company's ability to maintain its minimum cash requirement, fund its future cash interest requirements under its senior term loan and fund its operations depend in part on general economic, financial, competitive, legislative, regulatory and other conditions that may be beyond the Company's control. Accordingly, the Company continues to closely monitor expenses to assess whether any immediate, or long-term changes, are necessary to maintain compliance with its financial covenants. The Company’s cash, cash equivalents, restricted cash, and short-term investments were $ 44.5 million at March 31, 2024, compared with $ 24.4 million at December 31, 2023. Further, the Company had a negative working capital balance of $ 38.5 million (excluding cash and short-term investments) at March 31, 2024 and had an accumulated deficit of $ 765.8 million and $ 816.4 million as of March 31, 2024 and December 31, 2023, respectively. The Company has incurred net losses of $ 21.0 million (excluding the effect of the gain on sale of business) and $ 19.3 million for the three months ended March 31, 2024 and 2023, respectively. Management expects that significant on-going operating and capital expenditures will be necessary to continue to implement the Company’s business plan of entering new markets, future acquisitions, and infrastructure and product development. In addition, as disclosed in Note 8, “Debt”, the Company is subject to certain financial covenants. The Company’s ability to maintain compliance with these financial covenants are based on the Company’s current expectations regarding continued growth in revenues, collections, cost structure, current cash burn rate and other operating assumptions. The Company believes our cash on hand at March 31, 2024, proceeds from our expected product sales, and available borrowings under our Senior Term Loan for certain acquisition activity, will be sufficient to meet our obligations and our required covenants for at least the next twelve months from the date of this filing .
Segments	Segments The Company operates as one operating segment. Operating segments are defined as components of an enterprise for which separate financial information is evaluated regularly by the chief operating decision maker (“CODM”) in deciding how to allocate resources and assess performance. Over the past several years, the Company has completed a number of acquisitions. These acquisitions have allowed the Company to expand its offerings, presence, and reach in various market segments. While the Company has offerings in multiple market segments and operates in multiple countries, the Company’s business operates in one operating segment because the Company’s CODM evaluates the Company’s financial information and resources, and assesses the performance of these resources, on a consolidated basis.
Earnings per Share	Earnings per Share Basic earnings per share (EPS) is calculated by dividing the net income or loss available to common stockholders by the weighted average number of shares of common stock outstanding for the period without consideration for common stock equivalents. Diluted EPS is computed by dividing the net income or loss available to common stockholders by the weighted average number of shares of common stock outstanding for the period and the weighted average number of dilutive common stock equivalents outstanding for the period determined using the if-converted method (convertible debt instruments) or treasury-stock method (warrants and share-based payment arrangements). For purposes of this calculation, common stock issuable upon conversion of debt, options and warrants are considered to be common stock equivalents and are only included in the calculation of diluted earnings per share when their effect is dilutive.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company has elected the fair value option on the subordinated convertible promissory notes issued as part of the Dragonfly acquisition, refer to Note 4, "Business Combinations" and Note 8, "Debt" for further details, and for the New GPO Note and Era Convertible Notes, refer to Note 8, "Debt" for further details. The Company records changes in fair value through the condensed consolidated statement of operations where the portion of the change that results from a change in the instrument-specific credit risk is recorded separately in accumulated other comprehensive income, if applicable. Additionally, under the fair value option, all issuance costs are expensed in the period that the debt is incurred.
Investments	Investments The Company has invested in highly liquid investments that have investment-grade ratings. These investments are accounted for at fair value through the condensed consolidated statement of operations. The Company is able to easily liquidate these into cash; accordingly, the Company has presented these investments as available for current operations and are presented as short-term investments within current assets in the condensed consolidated balance sheets. Purchases and sales of short-term investments are classified in the investing section of our consolidated statement of cash flows.
Concentration Risks	Concentrations of Risks Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company generally maintains its cash and cash equivalents with various nationally recognized financial institutions. The Company’s cash and cash equivalents at times exceed amounts guaranteed by the Federal Deposit Insurance Corporation. The Company considers cash on deposit and all highly liquid investments with original maturities of three months or less to be cash and cash equivalents. At March 31, 2024 , approximately 77 % of the Company’s cash and cash equivalents were held at JPMorgan Chase Bank, N.A. The Company does not require collateral for accounts receivable. The Company maintains an allowance for its doubtful accounts receivable due to estimated credit losses. This allowance is based upon historical loss patterns, the number of days billings are past due, collection history of each customer, an evaluation of the potential risk of loss associated with delinquent accounts and current market conditions and reasonable and supportable forecasts of future economic conditions to inform adjustments to historical loss patterns. The Company records the allowance against bad debt expense through the condensed consolidated statements of operations, included in sales and marketing expense, up to the amount of revenues recognized to date. Any incremental allowance is recorded as an offset to deferred revenue on the condensed consolidated balance sheets. Receivables are written off and charged against the recorded allowance when the Company has exhausted collection efforts without success. As of March 31, 2024 and December 31, 2023 , allowance for credit losses of $ 1,120 and $ 1,252 , respectively, was included in the accounts receivable, net balance. No single customer accounted for more than 10 % of the Company's accounts receivable balance as of March 31, 2024 and December 31, 2023. Revenue derived from the U.S. Federal Government was 17 % of revenue for both of the three months ended March 31, 2024 and 2023, respectively. As of both of March 31, 2024 and December 31, 2023 , assets located in the United States were approximately 85 % percent of total assets. As of March 31, 2024 one vendor accounted for more than 10 % of the Company's accounts payable balance. No vendors individually accounted for more than 10 % of the Company’s accounts payable as of December 31, 2023 . During the three months ended March 31, 2024 and March 31, 2023, one vendor represented more than 10 % of the total purchases made.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements In June 2016, the FASB issued ASU 2016-13 Financial Instruments – Credit Losses (ASC 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13") guidance with respect to measuring credit losses on financial instruments, including trade receivables. The guidance eliminates the probable initial recognition threshold that was previously required prior to recognizing a credit loss on financial instruments. The credit loss estimate now reflects an entity's current estimate of all future expected credit losses. Under the previous guidance, an entity only considered past events and current conditions. The Company adopted ASC 2016-13 on January 1, 2023 using the modified retrospective transition method. Upon adoption, the Company recorded a $ 212 cumulative-effect adjustment to accumulated deficit on the condensed consolidated balance sheets, our allowance for doubtful accounts receivable changed from $ 468 at December 31, 2022 to $ 680 at January 1, 2023 . In August 2020, the FASB issued ASU 2020-06 Debt – Debt with Conversion and Other Options (ASC 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (ASC 815-40) ("ASU 2020-06") guidance modifying the requirements for the accounting for convertible instruments and contracts in an entity’s own equity. The modifications eliminate certain accounting models for convertible debt instruments, eliminate certain requirements for equity classification of embedded derivatives and align earnings per share calculations for convertible instruments. The Company adopted ASC 2020-06 on January 1, 2023 using the modified retrospective approach. The adoption of ASC 2020-06 did not have a material impact on the Company's condensed consolidated financial statements. Recent Accounting Pronouncements Not Yet Effective In November 2023, the FASB issued ASU 2023-07 Segment Reporting (Topic 280) guidance for segment reporting. The new guidance amends segment reporting to include significant segment expenses. The guidance is effective for the Company beginning with our annual report for the year ended December 31, 2024, and the subsequent interim periods and is required to be disclosed retrospectively to all prior periods presented. The Company does not expect that this guidance will have a significant impact on our disclosures. In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures . The amendments in the ASU enhance income tax disclosures, primarily through standardization, disaggregation of rate reconciliation categories, and income taxes paid by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption allowed. We are currently evaluating the impact of adoption on our financial disclosures.

Revenues (Tables)

Revenues (Tables)	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	The following table depicts the Company's disaggregated revenue for the periods presented: Three Months Ended March 31, 2024 2023 Subscription $ 29,626 $ 28,467 Advisory 1,257 1,113 Advertising 514 418 Books 148 584 Other revenue 567 947 Total $ 32,112 $ 31,529
Schedule of Revenue by Geographic Operations	The following table depicts the Company’s revenue by geographic operations for the periods presented: Three Months Ended March 31, 2024 2023 North America $ 25,997 $ 26,152 Europe 5,269 4,100 Australia 303 289 Asia 543 988 Total $ 32,112 $ 31,529
Schedule of Deferred Revenue	Details of the Company’s deferred revenue for the periods presented are as follows: Balance at December 31, 2022 $ 36,487 Acquired deferred revenue 4,013 Revenue recognized in the current period from amounts in the prior balance ( 16,610 ) New deferrals, net of amounts recognized in the current period 25,928 Effects of foreign currency 32 Balance at March 31, 2023 $ 49,850 Balance at December 31, 2023 $ 44,405 Sale of Board.org ( 9,117 ) Revenue recognized in the current period from amounts in the prior balance ( 19,249 ) New deferrals, net of amounts recognized in the current period 29,502 Effects of foreign currency ( 118 ) Balance at March 31, 2024 $ 45,423

Acquisitions and Dispositions (

Acquisitions and Dispositions (Tables)	3 Months Ended
	Mar. 31, 2024
Business Acquisition [Line Items]
Summary of Contingent Consideration	The contingent liabilities from acquisitions are clas sified as Level 3 in the fair value hierarchy. At March 31, 2024 and December 31, 2023, the contingent consideration and compensation relates to the following acquisitions: March 31, 2024 December 31, 2023 Curate $ - $ 4 Equilibrium 113 112 DT Global - 14 Total contingent liabilities from acquisitions $ 113 $ 130
Dragonfly Eye Limited
Business Acquisition [Line Items]
Summary of Fair Value of Consideration Transferred	The acquisition date fair value of the consideration transferred for Dragonfly consisted of the following: Cash $ 5,617 Fair value of Class A common stock 9,539 Fair value of Seller Convertible Notes 8,635 Fair value of contingent consideration 1,445 Total $ 25,236
Summary of Fair Values of Assets Acquired and Liabilities Assumed	The following table summarizes the fair values of assets acquired and liabilities assumed as of the date of acquisition: Cash and cash equivalents $ 607 Current assets, net 3,690 Property and equipment, net 18 Intangible assets 9,600 Deferred revenues ( 3,933 ) Current liabilities ( 1,764 ) Deferred tax liabilities ( 1,517 ) Total net assets acquired 6,701 Goodwill 18,535 Total purchase price $ 25,236
Summary of Components of Identified Intangible Assets Acquired and Estimated Useful Lives	The following table sets forth the components of identified intangible assets acquired and their estimated useful lives as of the date of acquisition: Estimated Fair Value Estimated Useful Life (Years) Customer relationships $ 7,300 6 , 10 (a) Developed technology 1,750 10 Tradename 550 3 Total intangible assets acquired $ 9,600 (a) Includes two separate customer relationships with two different useful lives

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Summary of Lease Expense	The following table details the composition of lease expense for the periods presented: Three Months Ended March 31, 2024 2023 Operating lease cost $ 1,238 $ 2,585 Variable lease cost 94 155 Short-term lease cost 37 178 Total lease costs $ 1,369 $ 2,918 Sublease income $ ( 26 ) $ ( 1,364 )

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2024
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Summary of Gross Carrying Amounts and Accumulated Amortization of Intangible Assets by Major Class	The following table summarizes the gross carrying amounts and accumulated amortization of the Company’s intangible assets by major class: March 31, 2024 December 31, 2023 Weighted Average Gross Carrying Amount Accumulated Amortization Accumulated Impairment Net Gross Carrying Amount Accumulated Amortization Impairment Net Remaining Useful Life (Years) March 31, 2024 Customer relationships $ 76,071 $ ( 27,116 ) $ ( 2,235 ) $ 46,720 $ 88,544 $ ( 32,392 ) $ ( 2,235 ) $ 53,917 8.5 Developed technology 29,968 ( 20,338 ) ( 1,909 ) 7,721 37,205 ( 26,743 ) ( 1,909 ) 8,553 6.7 Databases 29,864 ( 11,590 ) - 18,274 29,895 ( 11,057 ) - 18,838 8.6 Tradenames 11,119 ( 3,789 ) ( 579 ) 6,751 12,077 ( 4,367 ) ( 579 ) 7,131 8.2 Expert network 2,669 ( 1,391 ) - 1,278 2,692 ( 1,291 ) - 1,401 2.9 Patents 803 ( 213 ) ( 8 ) 582 784 ( 217 ) ( 8 ) 559 17.5 Content library 592 ( 138 ) - 454 592 ( 123 ) - 469 7.7 Total $ 151,086 $ ( 64,575 ) $ ( 4,731 ) $ 81,780 $ 171,789 $ ( 76,190 ) $ ( 4,731 ) $ 90,868 F
Schedule of Expected Future Amortization Expense for Intangible Assets	The expected future amortization expense for intangible assets as of March 31, 2024 is as follows: 2024 (remainder) $ 8,800 2025 10,441 2026 10,183 2027 9,774 2028 9,427 Thereafter 33,155 Total $ 81,780
Schedule of Capitalized Software Development Costs	Capitalized software development costs are as follows. March 31, 2024 December 31, 2023 Gross Carrying Amount Accumulated Amortization Accumulated Impairment Net Gross Carrying Amount Accumulated Amortization Impairment Net Capitalized software development costs $ 27,008 $ ( 11,754 ) $ ( 1,492 ) $ 13,762 $ 27,659 $ ( 12,795 ) $ ( 1,492 ) $ 13,372

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
	Mar. 31, 2024
Goodwill [Roll Forward]
Summary of Changes in Carrying Amounts of Goodwill	The changes in the carrying amounts of goodwill, which are generally not deductible for tax purposes, are as follows: Balance at December 31, 2023 $ 187,703 Sale of Board.org ( 23,022 ) Impact of foreign currency fluctuations ( 347 ) Balance at March 31, 2024 $ 164,334

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Summary of Carrying Value of Debt	The following presents the carrying value of the Company’s debt as of the respective period ends: March 31, 2024 December 31, 2023 Senior Term Loan $ 92,891 $ 158,228 New GPO Note 33,252 36,954 Convertible Notes 14,557 14,052 Dragonfly Seller Convertible Notes 7,857 9,002 Era Convertible Note 8,461 5,977 Aicel Convertible Note 1,114 1,156 PPP loan 117 144 Total gross debt 158,249 225,513 Debt issuance costs ( 5,220 ) ( 3,098 ) Total 153,029 222,415 Less: Current portion ( 67 ) ( 105 ) Total $ 152,962 $ 222,310
Summary of Estimated Fair Value of Debt	The following table summarizes the total estimated fair value of the Company's debt as of March 31, 2024 and December 31, 2023, respectively. These fair values are deemed Level 3 liabilities within the fair value measurement framework. March 31, 2024 December 31, 2023 Senior Term Loan $ 92,497 $ 168,702 New GPO Note 33,252 36,954 Convertible Notes 13,709 13,992 Dragonfly Seller Convertible Notes 7,857 10,407 Era Convertible Notes 8,461 5,977 Total $ 155,776 $ 236,032

Transaction (Gains) Costs, net

Transaction (Gains) Costs, net (Tables)	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Summary of Transaction Costs Related to Businesses Acquired and Consummation of Business Combination	The Company incurred the following transaction costs related to businesses acquired and the consummation of the Business Combination during the periods presented: Three Months Ended March 31, 2024 2023 Transaction costs related to acquired businesses $ - $ 1,222 Non-capitalizable Business Combination costs - 184 Change in contingent consideration liabilities ( 4 ) ( 156 ) Contingent compensation expense - 158 Total transaction (gains) costs, net $ ( 4 ) $ 1,408

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Components of Basic and Diluted Loss Per Shares	The following is a calculation of the basic and diluted earnings per share for the Company's common stock, including a reconciliation between net income attributable to common stockholders used for Basic EPS and Diluted EPS for the three months ended March 31, 2024 and 2023: (in thousands, except per share data) Three Months Ended March 31, 2024 2023 Basic Earnings Per Share Numerator: Net income (loss) attributable to common stockholders $ 50,599 $ ( 19,273 ) Denominator: Weighted average common stock outstanding used in basic EPS computations 130,712,032 133,082,639 Basic Earnings Per Share $ 0.39 $ ( 0.14 ) Diluted Earnings Per Share Numerator: Net income (loss) attributable to common stockholders $ 50,599 $ ( 19,273 ) If-converted impact on net income (loss) attributable to common stockholders 3,673 - Net income (loss) attributable to common stockholders for diluted EPS $ 54,272 $ ( 19,273 ) Denominator: Weighted average common stock outstanding used in basic EPS computations 130,712,032 133,082,639 Weighted average effect of dilutive securities 15,315,053 - Weighted average common stock outstanding used in diluted EPS computations 146,027,085 133,082,639 Diluted Earnings Per Share $ 0.37 $ ( 0.14 )
Summary of Anti Dilutive Securities Excluded from Calculations of Diluted Per Share	Potentially dilutive securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: Three Months Ended March 31, Anti-dilutive securities excluded from diluted loss per share: 2024 2023 Anti-dilutive Earnout Awards 19,195,100 19,195,100 Anti-dilutive stock options - 2,033,574 Anti-dilutive Convertible Notes - 2,075,225 Anti-dilutive contingently issuable shares - 1,339,924 Anti-dilutive restricted stock units 5,569,966 7,022,744 Anti-dilutive Aicel Convertible Notes - 112,899 Total anti-dilutive securities excluded from diluted loss per share 24,765,066 31,779,466

Provision (Benefit) from Inco_2

Provision (Benefit) from Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2024
Income Tax Disclosure [Abstract]
Summary of Activities Relating to Unrecognized Tax Benefits	The Company has the following activities relating to unrecognized tax benefits for the periods presented: Beginning balances at December 31, 2023 and 2022 $ 639 $ 639 Lapses in statutes of limitations - - Ending balances at March 31, 2024 and 2023 $ 639 $ 639

Fair Value Measurements and D_2

Fair Value Measurements and Disclosures (Tables)	3 Months Ended
	Mar. 31, 2024
Schedule of Fair Value on a Recurring Basis	The following table presents the Company’s financial assets and liabilities accounted for at fair value on a recurring basis as of March 31, 2024 by level within the fair value hierarchy: Level 1 Level 2 Level 3 Total Assets: Cash equivalents $ 3,157 $ - $ - $ 3,157 Short-term investments - 7,134 - 7,134 Liabilities: Public warrants $ 2,090 $ - $ - $ 2,090 Private placement warrants - 1,750 - 1,750 Contingent liabilities from acquisitions - - 113 113 New GPO Note - - 33,252 33,252 Dragonfly Seller Convertible Notes - - 7,857 7,857 Era Convertible Note - - 8,461 8,461 The following table presents the Company’s financial assets and liabilities accounted for at fair value on a recurring basis as of December 31, 2023 by level within the fair value hierarchy: Level 1 Level 2 Level 3 Total Assets: Cash equivalents $ 3,044 $ - $ - $ 3,044 Short-term investments - 7,134 - 7,134 Liabilities: Public warrants $ 2,591 $ - $ - $ 2,591 Private placement warrants - 2,170 - 2,170 Contingent liabilities from acquisitions - - 130 130 Liability classified warrants (a) - - 23 23 New GPO Note - - 36,954 36,954 Dragonfly Seller Convertible Notes - - 9,002 9,002 Era Convertible Note - - 5,977 5,977 (a) - Included in other non-current liabilities on the condensed consolidated balance sheets
Summary of Changes in Fair Value of Level 3 Liabilities	The following table summarizes changes in fair value of the Company’s level 3 liabilities during the periods presented : Contingent Liability Classified Warrants New GPO Note Dragonfly Seller Convertible Notes Era Convertible Note Balance at December 31, 2023 $ 130 $ 23 $ 36,954 $ 9,002 $ 5,977 Fair value at issuance date - - - - 801 Change in fair value included in the determination of net (income) loss (a) ( 3 ) ( 23 ) ( 180 ) ( 47 ) 1,683 Change in fair value included in accumulated other comprehensive income - - ( 4,443 ) ( 1,264 ) - Cash contingent consideration earned and subsequently settled ( 14 ) - - - - Paid in kind interest - - 921 241 - Foreign exchange - - - ( 75 ) - Balance at March 31, 2024 $ 113 $ - $ 33,252 $ 7,857 $ 8,461 (a) The change in contingent liabilities from acquisitions is recorded as transaction costs on the condensed consolidated statements of operations and comprehensive income (loss).
Summary of Contingent Consideration and Compensation Related to Acquisitions	The contingent liabilities from acquisitions are clas sified as Level 3 in the fair value hierarchy. At March 31, 2024 and December 31, 2023, the contingent consideration and compensation relates to the following acquisitions: March 31, 2024 December 31, 2023 Curate $ - $ 4 Equilibrium 113 112 DT Global - 14 Total contingent liabilities from acquisitions $ 113 $ 130
New GPO Note
Summary of Inputs and Assumptions	The following table presents the assumptions used to determine the fair value of the New GPO Note at March 31, 2024 and at December 31, 2023: March 31, 2024 December 31, 2023 Common stock share price $ 1.33 $ 1.14 Risk free rate 4.3 % 3.9 % Yield 18.5 % 14.5 % Expected volatility 50.0 % 50.0 % Expected term (years) 4.3 4.5
Dragonfly Seller Convertible Notes
Summary of Inputs and Assumptions	The following table presents the assumptions used to determine the fair value of the Dragonfly Seller Convertible Notes at March 31, 2024 and December 31, 2023: March 31, 2024 December 31, 2023 Common stock share price $ 1.33 $ 1.14 Risk free rate 4.3 % 3.9 % Yield 20.0 % 15.5 % Expected volatility 50.0 % 50.0 % Expected term (years) 3.8 4.1
Era Convertible Note
Summary of Inputs and Assumptions	The following table presents the assumptions used to determine the fair value of the Era Convertible Note at March 31, 2024 and December 31, 2023: March 31, 2024 December 31, 2023 Common stock share price $ 1.33 $ 1.14 Risk free rate 4.8 % 4.17 % Yield 156.1 % 153.24 % Expected volatility 51.0 % 63.00 % Expected term (years) 3.7 3.9
Last Out Lender Warrants
Summary of Inputs and Assumptions	The Last Out Lender Warrants are classified as Level 3 in the fair value hierarchy. The fair value of the Last Out Lender Warrants is calculated using the Black-Scholes calculation with the following inputs: March 31, 2024 Common stock fair value $ 1.33 Time to maturity (years) 1.3 Risk free rate 4.88 % Volatility 52 % Exercise price $ 8.56

Summary of Business and Signi_3

Summary of Business and Significant Accounting Policies - Additional Information (Details) $ in Thousands	3 Months Ended		12 Months Ended
	Mar. 31, 2024 USD ($) Segment	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)	Jan. 01, 2023 USD ($)	Dec. 31, 2022 USD ($)
Significant Accounting Policies [Line Items]
Cash, cash equalents, restricted cash, and short-term investments	$ 44,500		$ 24,400
Working capital deficit	38,500
Accumulated deficit	(765,817)		(816,416)
Net income (loss)	50,599	$ (19,273)
Net losses excluding effect of gain on sale of business	$ 21,000
Number of operating segments | Segment	1
Percentage of cash and cash equivalents held	77%
Allowance for credit losses	$ 1,120		$ 1,252
ASU 2016-13
Significant Accounting Policies [Line Items]
Allowance for doubtful accounts receivable				$ 680
ASU 2016-13 | Previously Reported
Significant Accounting Policies [Line Items]
Allowance for doubtful accounts receivable					$ 468
ASU 2016-13 | Cumulative-Effect Adjustment
Significant Accounting Policies [Line Items]
Accumulated deficit				$ 212
Accounts Receivable | Customer Concentration Risk | Customer One
Significant Accounting Policies [Line Items]
Concentration risk, percentage	10%		10%
Revenue | Customer Concentration Risk | U.S. Federal Government
Significant Accounting Policies [Line Items]
Concentration risk, percentage	17%	17%
Assets | Geographic Concentration Risk | Single Customer | United States
Significant Accounting Policies [Line Items]
Concentration risk, percentage	85%		85%
Accounts Payable | Supplier Concentration Risk | Vendor
Significant Accounting Policies [Line Items]
Concentration risk, percentage	10%
Accounts Payable | Supplier Concentration Risk | Two Vendors
Significant Accounting Policies [Line Items]
Concentration risk, percentage			10%
Purchases | Supplier Concentration Risk | One Vendor
Significant Accounting Policies [Line Items]
Concentration risk, percentage	10%	10%

Business Combination with DSAC

Business Combination with DSAC - Additional Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)
Business Acquisition [Line Items]
Payments of transaction costs	$ 7,068
DSAC | Merger Agreement
Business Acquisition [Line Items]
Business combination description	Subsequent to the closing of the Business Combination, the Company's Class A common stock and public warrants began trading on the New York Stock Exchange (“NYSE”) under the symbols “NOTE” and “NOTE WS,” respectively. The Company accounted for the Business Combination as a reverse recapitalization whereby Old FiscalNote was determined as the accounting acquirer and DSAC as the accounting acquiree. Accordingly, the Business Combination was treated as the equivalent of Old FiscalNote issuing stock for the net assets of DSAC, accompanied by a recapitalization. The net assets of DSAC are stated at historical cost, with no goodwill or other intangible assets recorded.

Revenues - Schedule of Disaggre

Revenues - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation Of Revenue [Line Items]
Total revenues	$ 32,112	$ 31,529
Subscription
Disaggregation Of Revenue [Line Items]
Total revenues	29,626	28,467
Advisory
Disaggregation Of Revenue [Line Items]
Total revenues	1,257	1,113
Advertising
Disaggregation Of Revenue [Line Items]
Total revenues	514	418
Books
Disaggregation Of Revenue [Line Items]
Total revenues	148	584
Other Revenue
Disaggregation Of Revenue [Line Items]
Total revenues	$ 567	$ 947

Revenues - Revenue by Geographi

Revenues - Revenue by Geographic Locations (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation Of Revenue [Line Items]
Total revenues	$ 32,112	$ 31,529
North America
Disaggregation Of Revenue [Line Items]
Total revenues	25,997	26,152
Europe
Disaggregation Of Revenue [Line Items]
Total revenues	5,269	4,100
Australia
Disaggregation Of Revenue [Line Items]
Total revenues	303	289
Asia
Disaggregation Of Revenue [Line Items]
Total revenues	$ 543	$ 988

Revenues - Additional Informati

Revenues - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Disaggregation Of Revenue [Line Items]
Contract assets	$ 1,044,000		$ 1,183,000
Capitalized cost	941,000	$ 1,114,000
Impairments of costs to obtain revenue contracts	0	0
Revenue remaining performance obligation	90,981,000
Sales and Marketing Expense
Disaggregation Of Revenue [Line Items]
Capitalized cost, amortization	$ 1,009,000	$ 832,000
Geographic Concentration Risk | Revenue | Revenue
Disaggregation Of Revenue [Line Items]
Concentration risk, percentage	5%	5%
Geographic Concentration Risk | Revenue | United Kingdom
Disaggregation Of Revenue [Line Items]
Concentration risk, percentage	13%	10%

Revenues - Schedule of Deferred

Revenues - Schedule of Deferred Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Contract with Customer, Liability [Abstract]
Beginning balance	$ 44,405	$ 36,487
Acquired deferred revenue		4,013
Sale of Board.org	(9,117)
Revenue recognized in the current period from amounts in the prior balance	(19,249)	(16,610)
New deferrals, net of amounts recognized in the current period	29,502	25,928
Effects of foreign currency	(118)	32
Ending balance	$ 45,423	$ 49,850

Revenues - Additional Informa_2

Revenues - Additional Information (Details1)	Mar. 31, 2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2023-10-01
Disaggregation Of Revenue [Line Items]
Revenue remaining performance obligation, expected satisfaction period	3 months
Revenue, remaining performance obligation, expected timing of satisfaction, year	2023
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2024-01-01
Disaggregation Of Revenue [Line Items]
Revenue remaining performance obligation, expected satisfaction period	1 year
Revenue, remaining performance obligation, expected timing of satisfaction, year	2024
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2025-01-01
Disaggregation Of Revenue [Line Items]
Revenue remaining performance obligation, expected satisfaction period	1 year
Revenue, remaining performance obligation, expected timing of satisfaction, year	2025
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2026-01-01
Disaggregation Of Revenue [Line Items]
Revenue remaining performance obligation, expected satisfaction period	1 year
Revenue, remaining performance obligation, expected timing of satisfaction, year	2026
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date: 2027-01-01
Disaggregation Of Revenue [Line Items]
Revenue remaining performance obligation, expected satisfaction period	1 year
Revenue, remaining performance obligation, expected timing of satisfaction, year	2027

Acquisitions and Dispositions -

Acquisitions and Dispositions - Additional Information (Details) £ in Millions				3 Months Ended	12 Months Ended
	Mar. 11, 2024 USD ($)	Jan. 27, 2023 USD ($) shares	Jan. 27, 2023 GBP (£) shares	Mar. 31, 2024 USD ($)	Dec. 31, 2023 USD ($)	Jan. 27, 2023 GBP (£)
Business Acquisition [Line Items]
Pre-tax gain on disposal				$ 71,599,000
Employee Lease Agreement
Business Acquisition [Line Items]
Due from the buyer				$ 378,000
Board.Org
Business Acquisition [Line Items]
Prepayment and exit fees	$ 7,068,000
Net proceeds from sale of business	18,137,000
Current tax liability for federal and state income tax	1,448,000
Non-cash deferred tax charge	280,000
Board.Org | Term Loans
Business Acquisition [Line Items]
Prepayments of debt	65,700,000
Exec Connect Intermediate LLC | Board.Org | Purchase Agreement
Business Acquisition [Line Items]
Cash received	90,905,000
Escrow deposit	785,000
Cash acquired by the buyer	21,000
Earn-out payment received	8,000,000
Pre-tax gain on disposal	71,599,000
Estimated post-closing purchase price adjustment	$ 50,000
Dragonfly Eye Limited
Business Acquisition [Line Items]
Transaction costs					$ 1,272,000
Payment of transaction cost		$ 446,000
Business acquisition, goodwill, expected tax deductible amount		0
Cash consideration		5,617,000	£ 4.5
Dragonfly Eye Limited | Convertible Promissory Note
Business Acquisition [Line Items]
Carrying value of convertible notes		$ 11,100,000				£ 8.9
Dragonfly Eye Limited | Class A Common Stock
Business Acquisition [Line Items]
Shares issued in business acquisitions, shares | shares		1,885,149	1,885,149

Acquisitions and Dispositions_2

Acquisitions and Dispositions - Summary of Fair Value of Consideration Transferred (Details) - Jan. 27, 2023 - Dragonfly Eye Limited $ in Thousands, £ in Millions	USD ($)	GBP (£)
Business Acquisition Contingent Consideration [Line Items]
Cash	$ 5,617	£ 4.5
Fair value of common stock	9,539
Fair value of contingent consideration	1,445
Fair value of Seller Convertible Notes	8,635
Total	$ 25,236

Acquisitions and Dispositions_3

Acquisitions and Dispositions - Summary of Fair Values of Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Jan. 27, 2023	Mar. 31, 2024	Dec. 31, 2023
Business Acquisition [Line Items]
Goodwill		$ 164,334	$ 187,703
Dragonfly Eye Limited
Business Acquisition [Line Items]
Cash and cash equivalents	$ 607
Current assets, net	3,690
Property and equipment, net	18
Intangible assets	9,600
Deferred revenues	(3,933)
Current liabilities	(1,764)
Deferred tax liabilities	(1,517)
Total net assets acquired	6,701
Goodwill	18,535
Total purchase price	$ 25,236

Acquisitions and Dispositions_4

Acquisitions and Dispositions - Summary of Components of Identified Intangible Assets Acquired and Estimated Useful Lives (Details) - Dragonfly Eye Limited $ in Thousands	Jan. 27, 2023 USD ($)
Acquired Finite Lived Intangible Assets [Line Items]
Estimated Fair Value	$ 9,600
Estimated Useful Life (Years)	6 years
Developed Technology
Acquired Finite Lived Intangible Assets [Line Items]
Estimated Fair Value	$ 1,750
Estimated Useful Life (Years)	10 years
Customer Relationships
Acquired Finite Lived Intangible Assets [Line Items]
Estimated Fair Value	$ 7,300
Estimated Useful Life (Years)	10 years
Tradename
Acquired Finite Lived Intangible Assets [Line Items]
Estimated Fair Value	$ 550
Estimated Useful Life (Years)	3 years

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Lessee Lease Description [Line Items]
Cash payment on operating lease liabilties	$ 1,499	$ 4,797
Payment of sublease termination Fee		$ 1,682
Minimum
Lessee Lease Description [Line Items]
Non-cancellable base terms	1 year
Maximum
Lessee Lease Description [Line Items]
Non-cancellable base terms	9 years

Leases - Summary of Lease Expen

Leases - Summary of Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Lease, Cost [Abstract]
Operating lease cost	$ 1,238	$ 2,585
Variable lease cost	94	155
Short-term lease cost	37	178
Total lease costs	1,369	2,918
Sublease income	$ (26)	$ (1,364)

Intangible Assets - Summary of

Intangible Assets - Summary of Gross Carrying Amounts and Accumulated Amortization of Intangible Assets by Major Class (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Finite Lived Intangible Assets [Line Items]
Intangible assets, Gross Carrying Amount	$ 151,086	$ 171,789
Intangible assets, Accumulated Amortization	(64,575)	(76,190)
Intangible assets, Accumulated Impairment	(4,731)	(4,731)
Intangible assets, Net Carrying Amount	81,780	90,868
Customer Relationships
Finite Lived Intangible Assets [Line Items]
Intangible assets, Gross Carrying Amount	76,071	88,544
Intangible assets, Accumulated Amortization	(27,116)	(32,392)
Intangible assets, Accumulated Impairment	(2,235)	(2,235)
Intangible assets, Net Carrying Amount	$ 46,720	53,917
Weighted Average Remaining Useful Life (Years)	8 years 6 months
Developed Technology
Finite Lived Intangible Assets [Line Items]
Intangible assets, Gross Carrying Amount	$ 29,968	37,205
Intangible assets, Accumulated Amortization	(20,338)	(26,743)
Intangible assets, Accumulated Impairment	(1,909)	(1,909)
Intangible assets, Net Carrying Amount	$ 7,721	8,553
Weighted Average Remaining Useful Life (Years)	6 years 8 months 12 days
Database
Finite Lived Intangible Assets [Line Items]
Intangible assets, Gross Carrying Amount	$ 29,864	29,895
Intangible assets, Accumulated Amortization	(11,590)	(11,057)
Intangible assets, Net Carrying Amount	$ 18,274	18,838
Weighted Average Remaining Useful Life (Years)	8 years 7 months 6 days
Tradename
Finite Lived Intangible Assets [Line Items]
Intangible assets, Gross Carrying Amount	$ 11,119	12,077
Intangible assets, Accumulated Amortization	(3,789)	(4,367)
Intangible assets, Accumulated Impairment	(579)	(579)
Intangible assets, Net Carrying Amount	$ 6,751	7,131
Weighted Average Remaining Useful Life (Years)	8 years 2 months 12 days
Expert Network
Finite Lived Intangible Assets [Line Items]
Intangible assets, Gross Carrying Amount	$ 2,669	2,692
Intangible assets, Accumulated Amortization	(1,391)	(1,291)
Intangible assets, Net Carrying Amount	$ 1,278	1,401
Weighted Average Remaining Useful Life (Years)	2 years 10 months 24 days
Patents
Finite Lived Intangible Assets [Line Items]
Intangible assets, Gross Carrying Amount	$ 803	784
Intangible assets, Accumulated Amortization	(213)	(217)
Intangible assets, Accumulated Impairment	(8)	(8)
Intangible assets, Net Carrying Amount	$ 582	559
Weighted Average Remaining Useful Life (Years)	17 years 6 months
Content Library
Finite Lived Intangible Assets [Line Items]
Intangible assets, Gross Carrying Amount	$ 592	592
Intangible assets, Accumulated Amortization	(138)	(123)
Intangible assets, Net Carrying Amount	$ 454	$ 469
Weighted Average Remaining Useful Life (Years)	7 years 8 months 12 days

Intangible Assets - Additional

Intangible Assets - Additional Information (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Intangible Assets Disclosure [Line Items]
Amortization of intangible assets	[1]	$ 2,685	$ 2,814
Interest capitalized on capitalized software development costs		132	117
Amortization of capitalized software development costs		1,663	1,281
Intangible Assets Excluding Developed Technology
Intangible Assets Disclosure [Line Items]
Amortization of intangible assets		2,685	2,814
Developed Technology
Intangible Assets Disclosure [Line Items]
Amortization of intangible assets		$ 765	$ 1,316
[1] Amounts include stock-based compensation expenses, as follows: Three Months Ended March 31, 2024 2023 Cost of revenues $ 101 $ 58 Research and development 310 390 Sales and marketing 426 360 Editorial 100 66 General and administrative 5,238 5,632

Intangible Assets - Schedule of

Intangible Assets - Schedule of Expected Future Amortization Expense for Intangible Assets (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]
2024 (remainder)	$ 8,800
2025	10,441
2026	10,183
2027	9,774
2028	9,427
Thereafter	33,155
Intangible assets, Net Carrying Amount	$ 81,780	$ 90,868

Intangible Assets - Schedule _2

Intangible Assets - Schedule of Capitalized Software Development Costs (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Capitalized Computer Software, Net [Abstract]
Capitalized software development costs, Gross Carrying Amount	$ 27,008	$ 27,659
Capitalized software development costs, Accumulated Amortization	(11,754)	(12,795)
Capitalized software development costs, Accumulated Impairment	(1,492)	(1,492)
Capitalized software development costs, Net Carrying Amount	$ 13,762	$ 13,372

Goodwill - Summary of Changes i

Goodwill - Summary of Changes in Carrying Amounts of Goodwill (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($)
Goodwill [Roll Forward]
Balance at December 31, 2023	$ 187,703
Sale of Board.org	(23,022)
Impact of foreign currency fluctuations	(347)
Balance at March 31, 2024	$ 164,334

Goodwill - Additional Informati

Goodwill - Additional Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2023 USD ($)
Goodwill [Line Items]
Impairment of goodwill	$ 5,837	[1]
Environmental, Sustainability, and Governance ("ESG")
Goodwill [Line Items]
Impairment of goodwill	$ 5,837
[1] Amounts include stock-based compensation expenses, as follows: Three Months Ended March 31, 2024 2023 Cost of revenues $ 101 $ 58 Research and development 310 390 Sales and marketing 426 360 Editorial 100 66 General and administrative 5,238 5,632

Debt - Summary of Carrying Valu

Debt - Summary of Carrying Value of Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total gross debt	$ 158,249	$ 225,513
Debt issuance costs	(5,220)	(3,098)
Total	153,029	222,415
Less: Current portion	(67)	(105)
Total	152,962	222,310
Senior Term Loan
Debt Instrument [Line Items]
Total gross debt	92,891	158,228
New GPO Note
Debt Instrument [Line Items]
Total gross debt	33,252	36,954
Convertible Notes
Debt Instrument [Line Items]
Total gross debt	14,557	14,052
Dragonfly Seller Convertible Notes
Debt Instrument [Line Items]
Total gross debt	7,857	9,002
Era Convertible Note
Debt Instrument [Line Items]
Total gross debt	8,461	5,977
Aicel Convertible Note
Debt Instrument [Line Items]
Total gross debt	1,114	1,156
PPP Loan
Debt Instrument [Line Items]
Total gross debt	$ 117	$ 144

Debt - Senior Term Loan - Addit

Debt - Senior Term Loan - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands					3 Months Ended
	Mar. 11, 2024	Aug. 03, 2023	Aug. 02, 2023	Mar. 17, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Sep. 30, 2023
Debt Instrument [Line Items]
Paid-in-kind interest					$ 2,035	$ 970
Debt issuance costs					5,220		$ 3,098
Earlier of Prepayment or July 29, 2023
Debt Instrument [Line Items]
Debt issuance costs		$ 1,734
Earlier of Prepayment or July 29, 2024
Debt Instrument [Line Items]
Debt issuance costs		2,034
Senior Term Loan Amendment
Debt Instrument [Line Items]
Maturity date				Jul. 15, 2027
Exericse price per share				$ 0.01
Principal amount approved				$ 6,000
Senior Term Loan Amendment | Class A Common Stock
Debt Instrument [Line Items]
Purchase of common stock				80,000
Senior Term Loan Amendment No 3
Debt Instrument [Line Items]
Prepayment fee		$ 8,970	$ 7,410
Senior Term Loan
Debt Instrument [Line Items]
Principal amount					150,000
Uncommitted incremental loan facility					$ 100,000
Percentage of monthly interest in cash					9%
Interest payable in kind					1%
Maturity date	Jul. 15, 2027				Jul. 29, 2027
Annual interest rate term					The annual interest of the Senior Term Loan consists of two components: a cash interest component of (a) the greater of (i) Prime Rate plus 5.0% per annum or (ii) 9.0% payable monthly, and (b) interest payable in kind component of 1.00% per annum, payable in kind monthly.
Prime rate percentage					8.50%
Pay down amount	$ 65,700
Earn out payment proceeds percentage	70%
Prepayment fee and exit fee percentage	5.75%
Payment of related prepayment	$ 1,314
Payment of exit fees	5,754
Minimum liquidity covenant	22,500
Cash interest					$ 4,911
Paid-in-kind interest					364
Deferred fees outstanding	5,250
Prepayment fee	$ 1,134				8,970
Amortization					646	$ 149
Unamortized debt discount					$ 4,629
Increase in interest rate event of default					5%
Senior Term Loan | Prior to July 30, 2024
Debt Instrument [Line Items]
Prepayment fee					2%
Senior Term Loan | Prior to July 30, 2025
Debt Instrument [Line Items]
Prepayment fee					1%
Senior Term Loan | On or After July 30, 2025
Debt Instrument [Line Items]
Prepayment fee								0%
Senior Term Loan | Earlier of Prepayment or July 29, 2024
Debt Instrument [Line Items]
Debt issuance costs					$ 2,034
Senior Term Loan | Prime Rate
Debt Instrument [Line Items]
Debt instrument, interest rate					5%

Debt - New GPO Note - Additiona

Debt - New GPO Note - Additional Information (Details) - New GPO Note - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Apr. 11, 2024	Jun. 30, 2023
Debt Instrument [Line Items]
Convertible note, acquisition fair value					$ 36,583
Non-cash loss contingency		$ 3,474	$ 11,700
Carrying value of convertible notes	$ 33,252	$ 36,954
Unrealized change in fair value	4,443
Non-cash gain (loss) of convertible note	180
Interest expense	921
Convertible Promissory Note
Debt Instrument [Line Items]
Debt instrument amount	$ 46,794
Annual effective interest rate	7.50%
Maturity date	Jul. 03, 2028
Convertible Promissory Note | Subsequent Event
Debt Instrument [Line Items]
Conversion price				$ 6.89
Class A Common Stock | Convertible Promissory Note
Debt Instrument [Line Items]
Shares returned on legal settlement	5,881,723
Conversion price	$ 8.28

Debt - Convertible Notes - Addi

Debt - Convertible Notes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Debt Instrument [Line Items]
Interest expense, net	$ 7,362	$ 6,681
Convertible Notes
Debt Instrument [Line Items]
Principal and accrued PIK balance	14,557
Interest expense	$ 598	$ 515

Debt - Dragonfly Seller Convert

Debt - Dragonfly Seller Convertible Notes - Additional Information (Details) $ / shares in Units, $ in Thousands, £ in Millions	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares	Mar. 31, 2023 USD ($)	Mar. 31, 2024 GBP (£)	Dec. 31, 2023 USD ($)
Debt Instrument [Line Items]
Paid-in-kind interest	$ 2,035	$ 970
Convertible Notes
Debt Instrument [Line Items]
Interest expense	598	515
Convertible Notes | Dragonfly Eye Limited
Debt Instrument [Line Items]
Principal amount	$ 11,050		£ 8.9
Paid-in-kind interest rate	8%
Maturity date	Jan. 27, 2028
Conversion price | $ / shares	$ 10
Convertible note, acquisition fair value	$ 8,635
Interest expense	241	153
Carrying value of convertible notes	7,857			$ 9,002
Unrealized change in fair value	1,264
Non-cash gain (loss) of convertible note	$ 47	$ 574

Debt - Era Convertible Note - A

Debt - Era Convertible Note - Additional Information (Details) - Era Convertible Note [Member] - USD ($) $ in Thousands			3 Months Ended
	Apr. 11, 2024	Dec. 08, 2023	Mar. 31, 2024	Jan. 05, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Principal amount			$ 9,500
Convertible notes exchanged for common stock		3,105,105
Subsequent Event
Debt Instrument [Line Items]
Carrying value of convertible notes	$ 1,600
Subsequent Event | Common Stock
Debt Instrument [Line Items]
Shares issued	3,003,268
Convertible Notes Payable [Member]
Debt Instrument [Line Items]
Convertible note		$ 5,500		$ 801
Principal amount			$ 6,301
Maturity date			Dec. 08, 2027
Convertible note, acquisition fair value		$ 5,500		$ 801
Carrying value of convertible notes			$ 8,461		$ 5,977
Non-cash gain (loss) of convertible note			$ 1,683

Debt - Aicel Convertible Note -

Debt - Aicel Convertible Note - Additional Information (Details) - Convertible Notes - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Debt Instrument [Line Items]
Interest expense	$ 598	$ 515
Aicel Technologies
Debt Instrument [Line Items]
Principal amount	$ 1,131
Paid-in-kind interest rate	1%
Percentage of increase in paid-in-kind interest rate	12%
Convertible note, acquisition fair value	$ 1,131
Maturity date	Jul. 27, 2027
Interest expense	$ 19	$ 3

Debt - PPP Loan - Additional In

Debt - PPP Loan - Additional Information (Details) - USD ($) $ in Thousands	Feb. 14, 2022	Apr. 13, 2020	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Long-term debt			$ 153,029	$ 222,415
PPP Loan
Debt Instrument [Line Items]
Forgiveness of debt	$ 7,667
Remaining balance of loan	$ 333
Debt instrument, term	5 years
Short-term debt			67
Long-term debt			$ 50
CARES Act | PPP Loan
Debt Instrument [Line Items]
Proceeds from issuance of debt		$ 8,000
Interest rate		1%

Debt - Summary of Estimated Fai

Debt - Summary of Estimated Fair Value of Debt (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument Fair Value Disclosure [Line Items]
Fair value of debt	$ 155,776	$ 236,032
Senior Term Loan
Debt Instrument Fair Value Disclosure [Line Items]
Fair value of debt	92,497	168,702
New GPO Note
Debt Instrument Fair Value Disclosure [Line Items]
Fair value of debt	33,252	36,954
Convertible Notes
Debt Instrument Fair Value Disclosure [Line Items]
Fair value of debt	13,709	13,992
Dragonfly Seller Convertible Notes
Debt Instrument Fair Value Disclosure [Line Items]
Fair value of debt	7,857	10,407
Era Convertible Notes
Debt Instrument Fair Value Disclosure [Line Items]
Fair value of debt	$ 8,461	$ 5,977

Debt - Warrants - Additional In

Debt - Warrants - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands	Mar. 31, 2024	Dec. 31, 2023	Mar. 17, 2023
Class of Warrant or Right [Line Items]
Warrant liabilities	$ 3,840	$ 4,761
Warrants Associated with Amendment 1
Class of Warrant or Right [Line Items]
Warrants outstanding			80,000
Exercise price			$ 0.01
Warrant liabilities	$ 106
Old FiscalNote Warrants
Class of Warrant or Right [Line Items]
Warrants outstanding	118,700
Exercise price	$ 8.56
Warrant liabilities	$ 0

Stockholders' Equity - Addition

Stockholders' Equity - Additional Information (Details) - $ / shares	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Class Of Stock [Line Items]
Shares authorized	1,809,000,000
Preferred stock, shares authorized	100,000,000
Preferred stock, par value per share	$ 0.0001
Preferred stock, shares issued	0
Preferred stock, shares outstanding	0
Class A Common Stock
Class Of Stock [Line Items]
Common stock, shares authorized	1,700,000,000	1,700,000,000
Par value	$ 0.0001	$ 0.0001
Common stock, shares, issued	122,749,497	121,679,829
Common stock, shares, outstanding	122,749,497	121,679,829
Class B Common Stock
Class Of Stock [Line Items]
Common stock, shares authorized	9,000,000	9,000,000
Par value	$ 0.0001	$ 0.0001
Common stock, shares, issued	8,290,921	8,290,921
Common stock, shares, outstanding	8,290,921	8,290,921

Earnout Shares and RSUs - Addit

Earnout Shares and RSUs - Additional Information (Details) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) Acquisition $ / shares shares	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-Based Payment Arrangement, Expense | $	$ 131	$ 1,124
Earnout Awards
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expiration period	5 years
Share-Based Payment Arrangement, Expense | $	$ 17,712
Unrecognized compensation expense | $	$ 546
Unrecognized compensation expense recognition period	1 year 6 months
Earnout Awards | Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Shares entitled to receive	19,195,100
Number of tranches | Acquisition	5
Earnout Awards | Share-Based Compensation Award Tranche One | Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares issued	3,839,020
Minimum dollar volume-weighted average share price | $ / shares	$ 10.5
Earnout Awards | Share-Based Compensation Award Tranche Two | Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares issued	3,839,020
Minimum dollar volume-weighted average share price | $ / shares	$ 12.5
Earnout Awards | Share-Based Compensation Award Tranche Three | Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares issued	3,839,020
Minimum dollar volume-weighted average share price | $ / shares	$ 15
Earnout Awards | Share-Based Compensation Award Tranche Four | Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares issued	3,839,020
Minimum dollar volume-weighted average share price | $ / shares	$ 20
Earnout Awards | Share-Based Compensation Award Tranche Five | Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares issued	3,839,020
Minimum dollar volume-weighted average share price | $ / shares	$ 25
Earnout Shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares issued	0
Earnout shares liability | $	$ 68		$ 68
Earnout RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares issued	0

Warrant Liabilities - Additiona

Warrant Liabilities - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands		3 Months Ended
	Jul. 29, 2022	Mar. 31, 2024
Private Placement Warrants
Class Of Warrant Or Right [Line Items]
Warrant to purchase of common stock shares issued	7,000,000
Warrants outstanding		7,000,000
Warrants exercised		0
Exercise price		$ 0.44
Warrant liability fair value		$ 3,840
New Fiscal Note
Class Of Warrant Or Right [Line Items]
Exercise price	$ 1.571428
New Fiscal Note | Common Class A | Maximum
Class Of Warrant Or Right [Line Items]
Warrants outstanding	24,750,000
Public Warrants
Class Of Warrant Or Right [Line Items]
Warrant to purchase of common stock shares issued	8,750,000
Warrants outstanding		8,358,964
Warrants exercised		0
Shares registered holders acquire from class A common stock		1.571428
Warrants expiration date		Jul. 29, 2027
Public Warrants | Class A Common Stock Equals or Exceeds $11.45 per Share
Class Of Warrant Or Right [Line Items]
Class of warrants, redemption price per unit	$ 0.01
Class of warrants, redemption notice period	30 days
Stock price	$ 11.45
Number of consecutive trading days for determining share price	20 days
Number of trading days for determining share price	30 days
Public Warrants | Class A Common Stock Equals or Exceeds $6.36 per Share
Class Of Warrant Or Right [Line Items]
Class of warrants, redemption price per unit	$ 0.1
Class of warrants, redemption notice period	30 days
Stock price	$ 6.36
Number of consecutive trading days for determining share price	10 days
Warrants exercisable redemption feature		In no event will the warrants be exercisable in connection with this redemption feature for more than 0.567 shares of Class A common stock per warrant (subject to adjustment).
Maximum exercisable per share under redemption feature	$ 0.567
Public Warrants | Common Class A
Class Of Warrant Or Right [Line Items]
Exercise price	$ 7.32
Old FiscalNote Warrants
Class Of Warrant Or Right [Line Items]
Warrants outstanding		118,700
Exercise price		$ 8.56

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Details) - USD ($) $ in Thousands			3 Months Ended
	Jan. 01, 2024	Jan. 01, 2023	Mar. 31, 2024	Mar. 31, 2023	Jul. 27, 2022
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation			$ 6,175	$ 6,506
2022 Long-Term Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of shares issued from outstanding number of shares			3%
Increase in share reserve	3,650,394	3,693,767	13,523,734
Stock-based compensation			$ 5,776	6,404
Stock based compensation expense related to acquisition earnouts			$ 169	169
2022 Long-Term Incentive Plan | Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock, shares reserved for issuance			4,219,656		20,285,600
2022 Long-Term Incentive Plan | Performance Stock Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock remaining outstanding			2,601,649
2022 Long-Term Incentive Plan | Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock issued			239,663
Stock remaining outstanding			5,499,350
2022 Long-Term Incentive Plan | Performance Based Restricted Stock Units
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock remaining outstanding			75,000
2022 Long-Term Incentive Plan | Employee Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock issued			1,271,410
Stock options outstanding			7,868,951
2022 Employee Stock Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of shares issued from outstanding number of shares			1%
Increase in share reserve	1,299,707	1,231,255	3,267,760
Number of shares issued			202,327
Stock-based compensation			$ 99	$ 102
Common stock fair market value			85%
2022 Employee Stock Purchase Plan | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Employee payroll deductions			15%
2022 Employee Stock Purchase Plan | Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Common stock, shares reserved for issuance			5,493,588

Transaction (Gains) Costs, ne_2

Transaction (Gains) Costs, net - Summary of Transaction Costs Related to Businesses Acquired and Consummation of Business Combination (Details) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Transaction Costs Gains [Line Items]
Transaction costs related to acquired businesses			$ 1,222
Non-capitalizable Business Combination costs			184
Change in contingent consideration liabilities		$ (4)	(156)
Contingent compensation (gain) expense			158
Total transaction costs (gains), net	[1]	$ (4)	$ 1,408
[1] Amounts include stock-based compensation expenses, as follows: Three Months Ended March 31, 2024 2023 Cost of revenues $ 101 $ 58 Research and development 310 390 Sales and marketing 426 360 Editorial 100 66 General and administrative 5,238 5,632

Earnings (Loss) Per Share - Add

Earnings (Loss) Per Share - Additional Information (Details)	3 Months Ended
	Mar. 31, 2024
Common Class A
Earnings Per Share Basic [Line Items]
Common stock, number of vote per share	one vote
Common Class B
Earnings Per Share Basic [Line Items]
Common stock, number of vote per share	twenty-five votes

Earnings (Loss) Per Share - Com

Earnings (Loss) Per Share - Components of Basic and Diluted Earnings (Loss) Per Shares (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Numerator:
Net income (loss) attributable to common stockholders	$ 50,599	$ (19,273)
If-converted impact on net income (loss) attributable to common stockholders	3,673
Net income (loss) attributable to common stockholders for diluted EPS	$ 54,272	$ (19,273)
Denominator:
Weighted average common stock outstanding used in basic EPS computations	130,712,032	133,082,639
Weighted average effect of dilutive securities	15,315,053
Weighted average common stock outstanding used in diluted EPS computations	146,027,085	133,082,639
Basic Earnings Per Share	$ 0.39	$ (0.14)
Diluted Earnings Per Share	$ 0.37	$ (0.14)

Earnings (Loss) Per Share - Sum

Earnings (Loss) Per Share - Summary of Anti Dilutive Securities Excluded from Calculations of Diluted Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities excluded from diluted loss per share:	24,765,066	31,779,466
Anti-dilutive Earnout Awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities excluded from diluted loss per share:	19,195,100	19,195,100
Anti-dilutive Stock Options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities excluded from diluted loss per share:		2,033,574
Anti-dilutive Convertible Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities excluded from diluted loss per share:		2,075,225
Anti-dilutive Contingently Issuable Shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities excluded from diluted loss per share:		1,339,924
Anti-dilutive Restricted Stock Units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities excluded from diluted loss per share:	5,569,966	7,022,744
Anti-dilutive Aicel Convertible Notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive securities excluded from diluted loss per share:		112,899

Provision (Benefit) from Inco_3

Provision (Benefit) from Income Taxes - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Tax expense	$ 1,426	$ 30
Pretax income (loss)	$ 52,025	$ (19,243)
Effective tax rates (as a percent)	2.74%	0.16%
U.S. statutory rate	21%	21%
Uncertain tax position totaling	$ 639
Discrete tax charge for impact of sale of Board.org	$ 1,729

Provision (Benefit) from Inco_4

Provision (Benefit) from Income Taxes - Summary of Activities Relating to Unrecognized Tax Benefits (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Tax Disclosure [Abstract]
Beginning balances	$ 639	$ 639
Lapses in statutes of limitations	0	0
Ending balances	$ 639	$ 639

Fair Value Measurements and D_3

Fair Value Measurements and Disclosures - Schedule of Fair Value on a Recurring Basis (Details) - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Short-term Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets	$ 7,134
Fair Value, Recurring Basis | Cash Equivalents
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets	3,157	$ 3,044
Fair Value, Recurring Basis | Short-term Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets	7,134	7,134
Fair Value, Recurring Basis | Public Warrants
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities	2,090	2,591
Fair Value, Recurring Basis | Private Placement Warrants
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities	1,750	2,170
Fair Value, Recurring Basis | Contingent Liabilities from Acquisitions
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities	113	130
Fair Value, Recurring Basis | Liability Classified Warrants
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities		23
Fair Value, Recurring Basis | New GPO Note
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities	33,252	36,954
Fair Value, Recurring Basis | Dragonfly Seller Convertible Notes
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities	7,857	9,002
Fair Value, Recurring Basis | Era Convertible Note
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities	8,461	5,977
Fair Value, Recurring Basis | Level 1 | Cash Equivalents
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets	3,157	3,044
Fair Value, Recurring Basis | Level 1 | Public Warrants
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities	2,090	2,591
Fair Value, Recurring Basis | Level 2 | Short-term Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Assets	7,134	7,134
Fair Value, Recurring Basis | Level 2 | Private Placement Warrants
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities	1,750	2,170
Fair Value, Recurring Basis | Level 3 | Contingent Liabilities from Acquisitions
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities	113	130
Fair Value, Recurring Basis | Level 3 | Liability Classified Warrants
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities		23
Fair Value, Recurring Basis | Level 3 | New GPO Note
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities	33,252	36,954
Fair Value, Recurring Basis | Level 3 | Dragonfly Seller Convertible Notes
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities	7,857	9,002
Fair Value, Recurring Basis | Level 3 | Era Convertible Note
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Liabilities	$ 8,461	$ 5,977

Fair Value Measurements and D_4

Fair Value Measurements and Disclosures - Summary of Changes in Fair Value of Level 3 Liabilities (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Paid-in-kind interest, net	$ 2,035	$ 970
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Change In Fair Value Of Financial Instruments
Level 3 | Contingent Liabilities from Acquisitions
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance	$ 130
Change in fair value included in the determination of net (income) loss	(3)
Cash contingent consideration earned and subsequently settled	(14)
Ending balance	113
Level 3 | Liability Classified Warrants
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance	23
Change in fair value included in the determination of net (income) loss	(23)
Level 3 | New GPO Note
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance	36,954
Change in fair value included in the determination of net (income) loss	(180)
Change in fair value included in accumulated other comprehensive income	(4,443)
Paid-in-kind interest, net	921
Ending balance	33,252
Level 3 | Dragonfly Seller Convertible Notes
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance	9,002
Change in fair value included in the determination of net (income) loss	(47)
Change in fair value included in accumulated other comprehensive income	(1,264)
Paid-in-kind interest, net	241
Foreign exchange	(75)
Ending balance	7,857
Level 3 | Era Convertible Note
Fair Value Liabilities Measured On Recurring Basis Unobservable Input Reconciliation [Line Items]
Beginning balance	5,977
Fair value at issuance date	801
Change in fair value included in the determination of net (income) loss	1,683
Ending balance	$ 8,461

Fair Value Measurements and D_5

Fair Value Measurements and Disclosures - Additional Information (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Dec. 08, 2023	Jun. 30, 2023	Jan. 27, 2023
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Maturity period for cash equivalents	three months or less
Earned cash contingent compensation other transfer of assets and liabilities between levels	$ 0	$ 0
Short-term Investments
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Non-cash gain (loss) of convertible note	49,000
Estimated fair value of short-term investments	7,134,000
Curate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Number of shares issued for settlement of contingent consideration		83,393
New GPO Note
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Non-cash gain (loss) of convertible note	180,000
Estimated fair value	33,252,000		$ 36,954,000		$ 36,583,000
Unrealized change in fair value	4,443,000
Dragonfly Seller Convertible Notes
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Business combination, liability recognized						$ 8,635,000
Estimated fair value of convertible note	7,857,000		9,002,000
Non-cash gain (loss) of convertible note	47,000	$ 573,000
Unrealized change in fair value	1,264,000
Difference between aggregate fair value and unpaid principal balance	4,490,000
Era Convertible Note
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Business combination, liability recognized	8,461,000		5,977,000	$ 5,500,000
Non-cash gain (loss) of convertible note	1,684,000
Convertible note	801,000
Public Warrants
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Estimated fair value of warrants	2,090,000		2,591,000
Non-cash gain (loss) in fair value of financial instruments	501,000	7,607,000
Private Placement Warrants
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Estimated fair value of warrants	1,750,000		$ 2,170,000
Non-cash gain (loss) in fair value of financial instruments	$ 420,000	$ 6,370,000

Fair Value Measurements and D_6

Fair Value Measurements and Disclosures - Summary of Inputs and Assumptions (Convertible Notes) (Details)	Mar. 31, 2024 USD ($) yr	Dec. 31, 2023 yr USD ($)
Common Stock Share Price | New GPO Note
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input	1.33	1.14
Common Stock Share Price | Dragonfly Seller Convertible Notes
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input	1.33	1.14
Common Stock Share Price | Era Convertible Note
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input	1.33	1.14
Risk Free Rate | New GPO Note
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input	4.3	3.9
Risk Free Rate | Dragonfly Seller Convertible Notes
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input	4.3	3.9
Risk Free Rate | Era Convertible Note
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input	4.8	4.17
Yield | New GPO Note
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input	18.5	14.5
Yield | Dragonfly Seller Convertible Notes
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input	20	15.5
Yield | Era Convertible Note
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input	156.1	153.24
Expected Volatility | New GPO Note
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input	50	50
Expected Volatility | Dragonfly Seller Convertible Notes
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input	50	50
Expected Volatility | Era Convertible Note
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input	51	63
Expected term (Years) | New GPO Note
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input	4.3	4.5
Expected term (Years) | Dragonfly Seller Convertible Notes
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input | yr	3.8	4.1
Expected term (Years) | Era Convertible Note
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Convertible notes measurement input | yr	3.7	3.9

Fair Value Measurements and D_7

Fair Value Measurements and Disclosures - Summary of Contingent Consideration and Compensation Related to Acquisitions (Details) - Level 3 - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Business Acquisition, Contingent Consideration [Line Items]
Total contingent liabilities from acquisitions	$ 113	$ 130
Curate
Business Acquisition, Contingent Consideration [Line Items]
Total contingent liabilities from acquisitions	0	4
Equilibrium
Business Acquisition, Contingent Consideration [Line Items]
Total contingent liabilities from acquisitions	113	112
DT Global
Business Acquisition, Contingent Consideration [Line Items]
Total contingent liabilities from acquisitions	$ 0	$ 14

Fair Value Measurements and D_8

Fair Value Measurements and Disclosures - Summary of Inputs and Assumptions (Warrants) (Details) - Last Out Lender Warrants	Mar. 31, 2024 USD ($)
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input	8.56
Share Price | Common Stock
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input	1.33
Time to Maturity
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input	1.3
Risk Free Rate
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input	4.88
Expected Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Warrants measurement input	52

Subsequent Events - Additional

Subsequent Events - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions	Apr. 11, 2024	Mar. 31, 2024	Dec. 31, 2023
Class A Common Stock
Subsequent Event [Line Items]
Common stock par value		$ 0.0001	$ 0.0001
Subsequent Event | Era Convertible Note
Subsequent Event [Line Items]
Carrying value of convertible notes	$ 1.6
Subsequent Event | Era Convertible Note | Common Stock
Subsequent Event [Line Items]
Shares issued	3,003,268